{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 467216, "items": [{"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T20:42:39Z", "timestamp": 1574282559517}, "reference-count": 20, "publisher": "Mary Ann Liebert Inc", "issue": "1", "license": [{"URL": "http://www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/", "start": {"date-parts": [[2009, 2, 1]], "date-time": "2009-02-01T00:00:00Z", "timestamp": 1233446400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Biotherapy and Radiopharmaceuticals"], "published-print": {"date-parts": [[2009, 2]]}, "DOI": "10.1089/cbr.2008.0547", "type": "journal-article", "created": {"date-parts": [[2009, 2, 25]], "date-time": "2009-02-25T22:36:17Z", "timestamp": 1235601377000}, "page": "35-40", "source": "Crossref", "is-referenced-by-count": 7, "title": ["Efficacy of Postoperative UFT (Tegafur/Uracil) Plus PSK Therapies in Elderly Patients with Resected Colorectal Cancer"], "prefix": "10.1089", "volume": "24", "author": [{"given": "Shin-Ichiro", "family": "Yoshitani", "sequence": "first", "affiliation": [{"name": "Department of Surgical Oncology, Kanazawa Medical University, Ishikawa, Japan."}]}, {"given": "Shigeki", "family": "Takashima", "sequence": "additional", "affiliation": [{"name": "Department of Surgical Oncology, Kanazawa Medical University, Ishikawa, Japan."}]}], "member": "278", "container-title": ["Cancer Biotherapy and Radiopharmaceuticals"], "language": "en", "link": [{"URL": "http://www.liebertpub.com/doi/pdf/10.1089/cbr.2008.0547", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 7, 30]], "date-time": "2018-07-30T22:16:41Z", "timestamp": 1532989001000}, "score": 108.57949, "issued": {"date-parts": [[2009, 2]]}, "references-count": 20, "journal-issue": {"published-print": {"date-parts": [[2009, 2]]}, "issue": "1"}, "alternative-id": ["10.1089/cbr.2008.0547"], "URL": "http://dx.doi.org/10.1089/cbr.2008.0547", "ISSN": ["1084-9785", "1557-8852"], "issn-type": [{"value": "1084-9785", "type": "print"}, {"value": "1557-8852", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T03:34:47Z", "timestamp": 1574134487213}, "reference-count": 32, "publisher": "Springer Science and Business Media LLC", "issue": "6", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2004, 8, 10]], "date-time": "2004-08-10T00:00:00Z", "timestamp": 1092096000000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Br J Cancer"], "published-print": {"date-parts": [[2004, 9]]}, "DOI": "10.1038/sj.bjc.6602101", "type": "journal-article", "created": {"date-parts": [[2004, 8, 12]], "date-time": "2004-08-12T13:01:24Z", "timestamp": 1092315684000}, "page": "1221-1223", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Reply: Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer"], "prefix": "10.1038", "volume": "91", "author": [{"given": "S", "family": "Ohwada", "sequence": "first", "affiliation": []}, {"given": "Y", "family": "Morishita", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2004, 8, 10]]}, "reference": [{"key": "BF6602101_CR1", "author": "T Akatsu", "first-page": "251", "year": "2004", "unstructured": "Akatsu T, Moirya S, Yoshida S, Shirao K, Ohashi Y, Kodaira S (2004) Adjuvant oral uracil and tegafur (UFT) improves survival after complete mesorectal excision (ME) of pathologic TNM stage III rectal cancer. In Proc Am Soc Clin Oncol, Vol. 23, pp 251, New Orleans", "volume-title": "In Proc Am Soc Clin Oncol"}, {"key": "BF6602101_CR2", "first-page": "373", "volume": "16", "author": "I Algarra", "year": "1997", "unstructured": "Algarra I, Collado A, Garrido F (1997) Protein bound polysaccharide PSK abrogates more efficiently experimental metastases derived from H-2 negative than from H-2 positive fibrosarcoma tumor clones. J Exp Clin Cancer Res 16: 373\u2013380", "journal-title": "J Exp Clin Cancer Res"}, {"key": "BF6602101_CR3", "doi-asserted-by": "publisher", "first-page": "2343", "DOI": "10.1056/NEJMoa032709", "volume": "350", "author": "T Andre", "year": "2004", "unstructured": "Andre T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, Topham C, Zaninelli M, Clingan P, Bridgewater J, Tabah-Fisch I, de Gramont A (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350: 2343\u20132351", "journal-title": "N Engl J Med"}, {"key": "BF6602101_CR4", "doi-asserted-by": "publisher", "first-page": "759", "DOI": "10.1097/00000658-200206000-00002", "volume": "235", "author": "MA Choti", "year": "2002", "unstructured": "Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD, Lillemoe KD, Yeo CJ, Cameron JL (2002) Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235: 759\u2013766", "journal-title": "Ann Surg"}, {"key": "BF6602101_CR5", "doi-asserted-by": "publisher", "first-page": "2938", "DOI": "10.1200/JCO.2000.18.16.2938", "volume": "18", "author": "A de Gramont", "year": "2000", "unstructured": "de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, Boni C, Cortes-Funes H, Cervantes A, Freyer G, Papamichael D, Le Bail N, Louvet C, Hendler D, de Braud F, Wilson C, Morvan F, Bonetti A (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18: 2938\u20132947", "journal-title": "J Clin Oncol"}, {"key": "BF6602101_CR6", "doi-asserted-by": "publisher", "first-page": "3605", "DOI": "10.1200/JCO.2002.04.123", "volume": "20", "author": "JY Douillard", "year": "2002", "unstructured": "Douillard JY, Hoff PM, Skillings JR, Eisenberg P, Davidson N, Harper P, Vincent MD, Lembersky BC, Thompson S, Maniero A, Benner SE (2002) Multicenter phase III study of uracil/tegafur and oral leucovorin vs fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 20: 3605\u20133616", "journal-title": "J Clin Oncol"}, {"key": "BF6602101_CR7", "doi-asserted-by": "publisher", "first-page": "775", "DOI": "10.1111/j.1349-7006.1992.tb01979.x", "volume": "83", "author": "T Ebina", "year": "1992", "unstructured": "Ebina T, Murata K (1992) Antitumor effect of PSK at a distant site: tumor-specific immunity and combination with other chemotherapeutic agents. Jpn J Cancer Res 83: 775\u2013782", "journal-title": "Jpn J Cancer Res"}, {"key": "BF6602101_CR8", "doi-asserted-by": "publisher", "first-page": "80", "DOI": "10.1056/NEJMe030087", "volume": "349", "author": "GJ Elfenbein", "year": "2003", "unstructured": "Elfenbein GJ (2003) Stem-cell transplantation for high-risk breast cancer. N Engl J Med 349: 80\u201382", "journal-title": "N Engl J Med"}, {"key": "BF6602101_CR9", "doi-asserted-by": "publisher", "first-page": "899", "DOI": "10.1016/0016-5085(94)90748-X", "volume": "106", "author": "G Francini", "year": "1994", "unstructured": "Francini G, Petrioli R, Lorenzini L, Mancini S, Armenio S, Tanzini G, Marsili S, Aquino A, Marzocca G, Civitelli S, Mariani L, De Sando D, Bovenga S, Lorenzi M (1994) Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer. Gastroenterology 106: 899\u2013906", "journal-title": "Gastroenterology"}, {"key": "BF6602101_CR10", "first-page": "59", "volume": "52", "author": "A Garcia-Lora", "year": "2003", "unstructured": "Garcia-Lora A, Martinez M, Pedrinaci S, Garrido F (2003) Different regulation of PKC isoenzymes and MAPK by PSK and IL-2 in the proliferative and cytotoxic activities of the NKL human natural killer cell line. Cancer Immunol Immunother 52: 59\u201364", "journal-title": "Cancer Immunol Immunother"}, {"key": "BF6602101_CR11", "doi-asserted-by": "publisher", "first-page": "191", "DOI": "10.1007/s002620100189", "volume": "50", "author": "A Garcia-Lora", "year": "2001", "unstructured": "Garcia-Lora A, Pedrinaci S, Garrido F (2001) Protein-bound polysaccharide K and interleukin-2 regulate different nuclear transcription factors in the NKL human natural killer cell line. Cancer Immunol Immunother 50: 191\u2013198", "journal-title": "Cancer Immunol Immunother"}, {"key": "BF6602101_CR12", "doi-asserted-by": "publisher", "first-page": "362", "DOI": "10.1002/(SICI)1097-0215(19970127)70:3<362::AID-IJC19>3.0.CO;2-H", "volume": "70", "author": "M Harada", "year": "1997", "unstructured": "Harada M, Matsunaga K, Oguchi Y, Iijima H, Tamada K, Abe K, Takenoyama M, Ito O, Kimura G, Nomoto K (1997) Oral administration of PSK can improve the impaired anti-tumor CD4+ T- cell response in gut-associated lymphoid tissue (GALT) of specific- pathogen-free mice. Int J Cancer 70: 362\u2013372", "journal-title": "Int J Cancer"}, {"key": "BF6602101_CR13", "first-page": "475", "volume": "4", "author": "K Hirose", "year": "1990", "unstructured": "Hirose K, Zachariae COC, Oppenheim JJ, Matsushima K (1990) Induction of gene expression and production of immunomodulating cytokines by PSK in human peripheral blood mononuclear cells. Lymphokine Res 4: 475\u2013483", "journal-title": "Lymphokine Res"}, {"key": "BF6602101_CR14", "unstructured": "IMPACT (1995) Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators. Lancet 345: 939\u2013944"}, {"key": "BF6602101_CR15", "unstructured": "IMPACTB2 (1999) Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators. J Clin Oncol 17: 1356\u20131363"}, {"key": "BF6602101_CR16", "doi-asserted-by": "publisher", "first-page": "638", "DOI": "10.1056/NEJMoa010580", "volume": "345", "author": "E Kapiteijn", "year": "2001", "unstructured": "Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, Leer JW, van de Velde CJ (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345: 638\u2013646", "journal-title": "N Engl J Med"}, {"key": "BF6602101_CR17", "doi-asserted-by": "publisher", "first-page": "1713", "DOI": "10.1056/NEJMoa032792", "volume": "350", "author": "H Kato", "year": "2004", "unstructured": "Kato H, Ichinose Y, Ohta M, Hata E, Tsubota N, Tada H, Watanabe Y, Wada H, Tsuboi M, Hamajima N (2004) A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med 350: 1713\u20131721", "journal-title": "N Engl J Med"}, {"key": "BF6602101_CR18", "doi-asserted-by": "publisher", "first-page": "457", "DOI": "10.1016/0140-6736(93)90207-W", "volume": "341", "author": "JK MacFarlane", "year": "1993", "unstructured": "MacFarlane JK, Ryall RD, Heald RJ (1993) Mesorectal excision for rectal cancer. Lancet 341: 457\u2013460", "journal-title": "Lancet"}, {"key": "BF6602101_CR19", "doi-asserted-by": "publisher", "first-page": "1023", "DOI": "10.1038/bjc.1990.431", "volume": "62", "author": "ST Malik", "year": "1990", "unstructured": "Malik ST, Talbot D, Clarke PI, Osborne R, Reznek R, Wrigley PF, Slevin ML (1990) Phase II trial of UFT in advanced colorectal and gastric cancer. Br J Cancer 62: 1023\u20131025", "journal-title": "Br J Cancer"}, {"key": "BF6602101_CR20", "unstructured": "NIH (1990) Adjuvant therapy for patients with colon and rectal cancer. JAMA 264: 1444\u20131450"}, {"key": "BF6602101_CR21", "doi-asserted-by": "publisher", "first-page": "295", "DOI": "10.1200/JCO.1998.16.1.295", "volume": "16", "author": "MJ O'Connell", "year": "1998", "unstructured": "O'Connell MJ, Laurie JA, Kahn M, Fitzgibbons Jr RJ, Erlichman C, Shepherd L, Moertel CG, Kocha WI, Pazdur R, Wieand HS, Rubin J, Vukov AM, Donohue JH, Krook JE, Figueredo A (1998) Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. J Clin Oncol 16: 295\u2013300", "journal-title": "J Clin Oncol"}, {"key": "BF6602101_CR22", "doi-asserted-by": "publisher", "first-page": "1003", "DOI": "10.1038/sj.bjc.6601619", "volume": "90", "author": "S Ohwada", "year": "2004", "unstructured": "Ohwada S, Ikeya T, Yokomori T, Kusaba T, Roppongi T, Takahashi T, Nakamura S, Kakinuma S, Iwazaki S, Ishikawa H, Kawate S, Nakajima T, Morishita Y (2004) Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study. Br J Cancer 90: 1003\u20131010", "journal-title": "Br J Cancer"}, {"key": "BF6602101_CR23", "doi-asserted-by": "publisher", "first-page": "135", "DOI": "10.1007/s005990050079", "volume": "29", "author": "S Pedrinaci", "year": "1999", "unstructured": "Pedrinaci S, Algarra I, Garrido F (1999) Protein-bound polysaccharide (PSK) induces cytotoxic activity in the NKL human natural killer cell line. Int J Clin Lab Res 29: 135\u2013140", "journal-title": "Int J Clin Lab Res"}, {"key": "BF6602101_CR24", "doi-asserted-by": "publisher", "first-page": "1787", "DOI": "10.1200/JCO.2001.19.6.1787", "volume": "19", "author": "R Porschen", "year": "2001", "unstructured": "Porschen R, Bermann A, Loffler T, Haack G, Rettig K, Anger Y, Strohmeyer G (2001) Fluorouracil plus leucovorin as effective adjuvant chemotherapy in curatively resected stage III colon cancer: results of the trial adjCCA- 01. J Clin Oncol 19: 1787\u20131794", "journal-title": "J Clin Oncol"}, {"key": "BF6602101_CR25", "unstructured": "QUASAR (2000) Comparison of fluorouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer: a randomised trial. QUASAR Collaborative Group. Lancet 355: 1588\u20131596"}, {"key": "BF6602101_CR26", "doi-asserted-by": "publisher", "first-page": "905", "DOI": "10.1056/NEJM200009283431302", "volume": "343", "author": "LB Saltz", "year": "2000", "unstructured": "Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ, Maroun JA, Ackland SP, Locker PK, Pirotta N, Elfring GL, Miller LL (2000) Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 343: 905\u2013914", "journal-title": "N Engl J Med"}, {"key": "BF6602101_CR27", "doi-asserted-by": "publisher", "first-page": "258", "DOI": "10.1007/s00253-002-1076-7", "volume": "60", "author": "SP Wasser", "year": "2002", "unstructured": "Wasser SP (2002) Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol 60: 258\u2013274", "journal-title": "Appl Microbiol Biotechnol"}, {"key": "BF6602101_CR28", "doi-asserted-by": "publisher", "first-page": "3553", "DOI": "10.1200/JCO.1999.17.11.3553", "volume": "17", "author": "N Wolmark", "year": "1999", "unstructured": "Wolmark N, Rockette H, Mamounas E, Jones J, Wieand S, Wickerham DL, Bear HD, Atkins JN, Dimitrov NV, Glass AG, Fisher ER, Fisher B (1999) Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project C-04. J Clin Oncol 17: 3553\u20133559", "journal-title": "J Clin Oncol"}, {"key": "BF6602101_CR29", "doi-asserted-by": "publisher", "first-page": "58", "DOI": "10.1097/00000658-200007000-00009", "volume": "232", "author": "K Yamaguchi", "year": "2000", "unstructured": "Yamaguchi K, Takagi Y, Aoki S, Futamura M, Saji S (2000) Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann Surg 232: 58\u201365", "journal-title": "Ann Surg"}, {"key": "BF6602101_CR30", "doi-asserted-by": "publisher", "first-page": "389", "DOI": "10.1007/BF01526559", "volume": "41", "author": "E Yefenof", "year": "1995", "unstructured": "Yefenof E, Gafanovitch I, Oron E, Bar M, Klein E (1995) Prophylactic intervention in radiation-leukemia-virus-induced murine lymphoma by the biological response modifier polysaccharide K. Cancer Immunol Immunother 41: 389\u2013396", "journal-title": "Cancer Immunol Immunother"}, {"key": "BF6602101_CR31", "first-page": "343", "volume": "18", "author": "H Zhang", "year": "2000", "unstructured": "Zhang H, Morisaki T, Matsunaga H, Sato N, Uchiyama A, Hashizume K, Nagumo F, Tadano J, Katano M (2000) Protein-bound polysaccharide PSK inhibits tumor invasiveness by down- regulation of TGF-beta1 and MMPs. Clin Exp Metastasis 18: 343\u2013352", "journal-title": "Clin Exp Metastasis"}, {"key": "BF6602101_CR32", "doi-asserted-by": "publisher", "first-page": "2088", "DOI": "10.1038/sj.onc.1206310", "volume": "22", "author": "H Zhang", "year": "2003", "unstructured": "Zhang H, Morisaki T, Nakahara C, Matsunaga H, Sato N, Nagumo F, Tadano J, Katano M (2003) PSK-mediated NF-kB inhibition augments docetaxel-induced apoptosis in human pancreatic cancer cells NOR-P1. Oncogene 22: 2088\u20132096", "journal-title": "Oncogene"}], "container-title": ["British Journal of Cancer"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/6602101.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/6602101", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/6602101.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 17]], "date-time": "2019-03-17T15:37:47Z", "timestamp": 1552837067000}, "score": 54.408165, "issued": {"date-parts": [[2004, 8, 10]]}, "references-count": 32, "journal-issue": {"published-print": {"date-parts": [[2004, 9]]}, "issue": "6"}, "alternative-id": ["BF6602101"], "URL": "http://dx.doi.org/10.1038/sj.bjc.6602101", "relation": {"cites": []}, "ISSN": ["0007-0920", "1532-1827"], "issn-type": [{"value": "0007-0920", "type": "print"}, {"value": "1532-1827", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T21:56:53Z", "timestamp": 1574114213235}, "reference-count": 41, "publisher": "Springer Science and Business Media LLC", "issue": "5", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2004, 3, 1]], "date-time": "2004-03-01T00:00:00Z", "timestamp": 1078099200000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Br J Cancer"], "published-print": {"date-parts": [[2004, 3]]}, "DOI": "10.1038/sj.bjc.6601619", "type": "journal-article", "created": {"date-parts": [[2004, 3, 2]], "date-time": "2004-03-02T18:18:31Z", "timestamp": 1078251511000}, "page": "1003-1010", "source": "Crossref", "is-referenced-by-count": 68, "title": ["Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study"], "prefix": "10.1038", "volume": "90", "author": [{"given": "S", "family": "Ohwada", "sequence": "first", "affiliation": []}, {"given": "T", "family": "Ikeya", "sequence": "additional", "affiliation": []}, {"given": "T", "family": "Yokomori", "sequence": "additional", "affiliation": []}, {"given": "T", "family": "Kusaba", "sequence": "additional", "affiliation": []}, {"given": "T", "family": "Roppongi", "sequence": "additional", "affiliation": []}, {"given": "T", "family": "Takahashi", "sequence": "additional", "affiliation": []}, {"given": "S", "family": "Nakamura", "sequence": "additional", "affiliation": []}, {"given": "S", "family": "Kakinuma", "sequence": "additional", "affiliation": []}, {"given": "S", "family": "Iwazaki", "sequence": "additional", "affiliation": []}, {"given": "H", "family": "Ishikawa", "sequence": "additional", "affiliation": []}, {"given": "S", "family": "Kawate", "sequence": "additional", "affiliation": []}, {"given": "T", "family": "Nakajima", "sequence": "additional", "affiliation": []}, {"given": "Y", "family": "Morishita", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2004, 3, 2]]}, "reference": [{"key": "BF6601619_CR1", "first-page": "373", "volume": "16", "author": "I Algarra", "year": "1997", "unstructured": "Algarra I, Collado A, Garrido F (1997) Protein bound polysaccharide PSK abrogates more efficiently experimental metastases derived from H-2 negative than from H-2 positive fibrosarcoma tumor clones. J Exp Clin Cancer Res 16: 373\u2013380", "journal-title": "J Exp Clin Cancer Res"}, {"key": "BF6601619_CR2", "doi-asserted-by": "publisher", "first-page": "3617", "DOI": "10.1200/JCO.2002.10.129", "volume": "20", "author": "J Carmichael", "year": "2002", "unstructured": "Carmichael J, Popiela T, Radstone D, Falk S, Borner M, Oza A, Skovsgaard T, Munier S, Martin C (2002) Randomized comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 20: 3617\u20133627", "journal-title": "J Clin Oncol"}, {"key": "BF6601619_CR3", "doi-asserted-by": "publisher", "first-page": "759", "DOI": "10.1097/00000658-200206000-00002", "volume": "235", "author": "MA Choti", "year": "2002", "unstructured": "Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD, Lillemoe KD, Yeo CJ, Cameron JL (2002) Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235: 759\u2013766", "journal-title": "Ann Surg"}, {"key": "BF6601619_CR4", "doi-asserted-by": "publisher", "first-page": "3605", "DOI": "10.1200/JCO.2002.04.123", "volume": "20", "author": "JY Douillard", "year": "2002", "unstructured": "Douillard JY, Hoff PM, Skillings JR, Eisenberg P, Davidson N, Harper P, Vincent MD, Lembersky BC, Thompson S, Maniero A, Benner SE (2002) Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 20: 3605\u20133616", "journal-title": "J Clin Oncol"}, {"key": "BF6601619_CR5", "doi-asserted-by": "publisher", "first-page": "775", "DOI": "10.1111/j.1349-7006.1992.tb01979.x", "volume": "83", "author": "T Ebina", "year": "1992", "unstructured": "Ebina T, Murata K (1992) Antitumor effect of PSK at a distant site: tumor-specific immunity and combination with other chemotherapeutic agents. Jpn J Cancer Res 83: 775\u2013782", "journal-title": "Jpn J Cancer Res"}, {"key": "BF6601619_CR6", "doi-asserted-by": "publisher", "first-page": "1884", "DOI": "10.1002/(SICI)1097-0142(19970515)79:10<1884::AID-CNCR7>3.0.CO;2-G", "volume": "79", "author": "J Feliu", "year": "1997", "unstructured": "Feliu J, Gonzalez Baron M, Espinosa E, Garcia Giron C, de la Gandara I, Espinosa J, Colmenarejo A, Jalon JI, Fernandez Y, de Castro J (1997) Uracil and tegafur modulated with leucovorin: an effective regimen with low toxicity for the treatment of colorectal carcinoma in the elderly. Oncopaz Cooperative Group. Cancer 79: 1884\u20131889", "journal-title": "Cancer"}, {"key": "BF6601619_CR7", "doi-asserted-by": "publisher", "first-page": "899", "DOI": "10.1016/0016-5085(94)90748-X", "volume": "106", "author": "G Francini", "year": "1994", "unstructured": "Francini G, Petrioli R, Lorenzini L, Mancini S, Armenio S, Tanzini G, Marsili S, Aquino A, Marzocca G, Civitelli S, Mariani L, De Sando D, Bovenga S, Lorenzi M (1994) Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer. Gastroenterology 106: 899\u2013906", "journal-title": "Gastroenterology"}, {"key": "BF6601619_CR8", "doi-asserted-by": "publisher", "first-page": "27", "DOI": "10.7326/0003-4819-129-1-199807010-00007", "volume": "129", "author": "RM Goldberg", "year": "1998", "unstructured": "Goldberg RM, Fleming TR, Tangen CM, Moertel CG, Macdonald JS, Haller DG, Laurie JA (1998) Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med 129: 27\u201335", "journal-title": "Ann Intern Med"}, {"key": "BF6601619_CR9", "doi-asserted-by": "publisher", "first-page": "1321", "DOI": "10.1016/S0039-6109(16)42587-9", "volume": "61", "author": "TB Grage", "year": "1981", "unstructured": "Grage TB, Moss SE (1981) Adjuvant chemotherapy in cancer of the colon and rectum: demonstration of effectiveness of prolonged 5-FU chemotherapy in a prospectively controlled, randomized trial. Surg Clin North Am 61: 1321\u20131329", "journal-title": "Surg Clin North Am"}, {"key": "BF6601619_CR10", "doi-asserted-by": "publisher", "first-page": "362", "DOI": "10.1002/(SICI)1097-0215(19970127)70:3<362::AID-IJC19>3.0.CO;2-H", "volume": "70", "author": "M Harada", "year": "1997", "unstructured": "Harada M, Matsunaga K, Oguchi Y, Iijima H, Tamada K, Abe K, Takenoyama M, Ito O, Kimura G, Nomoto K (1997) Oral administration of PSK can improve the impaired anti-tumor CD4+ T-cell response in gut-associated lymphoid tissue (GALT) of specific-pathogen-free mice. Int J Cancer 70: 362\u2013372", "journal-title": "Int J Cancer"}, {"key": "BF6601619_CR11", "doi-asserted-by": "publisher", "first-page": "107", "DOI": "10.1016/0006-291X(91)90492-P", "volume": "174", "author": "Y Hayashida", "year": "1991", "unstructured": "Hayashida Y, Kurimoto S, Yamamoto N (1991) Effect of lymphokine-activated killer cells on human retinoblastoma cells (Y-79) in vitro: enhancement of the activity by a polysaccharide preparation, krestin. Biochem Biophys Res Commun 174: 107\u2013114", "journal-title": "Biochem Biophys Res Commun"}, {"key": "BF6601619_CR12", "doi-asserted-by": "publisher", "first-page": "1461", "DOI": "10.1002/1097-0142(197610)38:4<1461::AID-CNCR2820380402>3.0.CO;2-7", "volume": "38", "author": "GA Higgins", "year": "1976", "unstructured": "Higgins GA, Humphrey E, Juler G, LeVeen HH, McCaughan J, Keehn RJ (1976) Adjuvant chemotherapy in the surgical treatment of large bowel cancer. Cancer 38: 1461\u20131467", "journal-title": "Cancer"}, {"key": "BF6601619_CR13", "first-page": "475", "volume": "9", "author": "K Hirose", "year": "1990", "unstructured": "Hirose K, Zachariae CO, Oppenheim JJ, Matsushima K (1990) Induction of gene expression and production of immunomodulating cytokines by PSK in human peripheral blood mononuclear cells. Lymphokine Res 9: 475\u2013483", "journal-title": "Lymphokine Res"}, {"key": "BF6601619_CR14", "unstructured": "IMPACT (1995) Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators. Lancet 345: 939\u2013944", "DOI": "10.1016/S0140-6736(95)90696-7", "doi-asserted-by": "crossref"}, {"key": "BF6601619_CR15", "doi-asserted-by": "publisher", "first-page": "152", "DOI": "10.1007/BF01517346", "volume": "40", "author": "M Kato", "year": "1995", "unstructured": "Kato M, Hirose K, Hakozaki M, Ohno M, Saito Y, Izutani R, Noguchi J, Hori Y, Okumoto S, Kuroda D, Nomura H, Nishimatsu S, Ohoyanagi (1995) Induction of gene expression for immunomodulating cytokines in peripheral blood mononuclear cells in response to orally administered PSK, an immunomodulating protein-bound polysaccharide. Cancer Immunol Immunother 40: 152\u2013156", "journal-title": "Cancer Immunol Immunother"}, {"key": "BF6601619_CR16", "first-page": "1645", "volume": "61", "author": "S Lacour", "year": "2001", "unstructured": "Lacour S, Hammann A, Wotawa A, Corcos L, Solary E, Dimanche-Boitrel MT (2001) Anticancer agents sensitize tumor cells to tumor necrosis factor-related apoptosis-inducing ligand-mediated caspase-8 activation and apoptosis. Cancer Res 61: 1645\u20131651", "journal-title": "Cancer Res"}, {"key": "BF6601619_CR17", "doi-asserted-by": "publisher", "first-page": "223", "DOI": "10.1056/NEJM199807233390403", "volume": "339", "author": "GJ Liefers", "year": "1998", "unstructured": "Liefers GJ, Cleton-Jansen AM, van de Velde CJ, Hermans J, van Krieken JH, Cornelisse CJ, Tollenaar RA (1998) Micrometastases and survival in stage II colorectal cancer. N Engl J Med 339: 223\u2013228", "journal-title": "N Engl J Med"}, {"key": "BF6601619_CR18", "doi-asserted-by": "publisher", "first-page": "457", "DOI": "10.1016/0140-6736(93)90207-W", "volume": "341", "author": "JK MacFarlane", "year": "1993", "unstructured": "MacFarlane JK, Ryall RD, Heald RJ (1993) Mesorectal excision for rectal cancer. Lancet 341: 457\u2013460", "journal-title": "Lancet"}, {"key": "BF6601619_CR19", "doi-asserted-by": "publisher", "first-page": "1023", "DOI": "10.1038/bjc.1990.431", "volume": "62", "author": "ST Malik", "year": "1990", "unstructured": "Malik ST, Talbot D, Clarke PI, Osborne R, Reznek R, Wrigley PF, Slevin ML (1990) Phase II trial of UFT in advanced colorectal and gastric cancer. Br J Cancer 62: 1023\u20131025", "journal-title": "Br J Cancer"}, {"key": "BF6601619_CR20", "doi-asserted-by": "publisher", "first-page": "123", "DOI": "10.1007/BF02050666", "volume": "35", "author": "T Mitomi", "year": "1992", "unstructured": "Mitomi T, Tsuchiya S, Iijima N, Aso K, Suzuki K, Nishiyama K, Amano T, Takahashi T, Murayama N, Oka H, Noto T, Ogawa N (1992) Randomized, controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. The Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum (Kanagawa). Dis Colon Rectum 35: 123\u2013130", "journal-title": "Dis Colon Rectum"}, {"key": "BF6601619_CR21", "doi-asserted-by": "publisher", "first-page": "352", "DOI": "10.1056/NEJM199002083220602", "volume": "322", "author": "CG Moertel", "year": "1990", "unstructured": "Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Goodman PJ, Ungerleider JS, Emerson WA, Tormey DC, Glick JH, Veeder MH, Mailliard JA (1990) Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322: 352\u2013358", "journal-title": "N Engl J Med"}, {"key": "BF6601619_CR22", "doi-asserted-by": "publisher", "first-page": "1298", "DOI": "10.1111/j.1349-7006.1994.tb02943.x", "volume": "85", "author": "H Morinaga", "year": "1994", "unstructured": "Morinaga H, Tazawa K, Tagoh H, Muraguchi A, Fujimaki M (1994) An in vivo study of hepatic and splenic interleukin-1 beta mRNA expression following oral PSK or LEM administration. Jpn J Cancer Res 85: 1298\u20131303", "journal-title": "Jpn J Cancer Res"}, {"key": "BF6601619_CR23", "first-page": "245a", "volume": "18", "author": "H Nakazato", "year": "1999", "unstructured": "Nakazato H, Ito K, Takagi H, Saji S, Koike A, Baba S, Mai M, Ohashi Y, Sakamoto J (1999) A randomized clinical trial on adjuvant immunochemotherapy with protein bound polysaccharide K (PSK) after curative resection of colon cancer. Proc Am Soc Clin Oncol 18: 245a", "journal-title": "Proc Am Soc Clin Oncol"}, {"key": "BF6601619_CR24", "doi-asserted-by": "publisher", "first-page": "1122", "DOI": "10.1016/S0140-6736(94)90233-X", "volume": "343", "author": "H Nakazato", "year": "1994", "unstructured": "Nakazato H, Koike A, Saji S, Ogawa N, Sakamoto J (1994) Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Study Group of Immunochemotherapy with PSK for Gastric Cancer. Lancet 343: 1122\u20131126", "journal-title": "Lancet"}, {"key": "BF6601619_CR25", "doi-asserted-by": "publisher", "first-page": "295", "DOI": "10.1200/JCO.1998.16.1.295", "volume": "16", "author": "MJ O'Connell", "year": "1998", "unstructured": "O'Connell MJ, Laurie JA, Kahn M, Fitzgibbons Jr RJ, Erlichman C, Shepherd L, Moertel CG, Kocha WI, Pazdur R, Wieand HS, Rubin J, Vukov AM, Donohue JH, Krook JE, Figueredo A (1998) Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer. J Clin Oncol 16: 295\u2013300", "journal-title": "J Clin Oncol"}, {"key": "BF6601619_CR26", "unstructured": "Ohwada S, Iino Y, Miyamoto Y (1994) Adjuvant immunochemotherapy for colorectal cancer. Recent Adv Chemother G785\u2013G789"}, {"key": "BF6601619_CR27", "doi-asserted-by": "publisher", "first-page": "867", "DOI": "10.1016/S0022-5223(96)70085-5", "volume": "112", "author": "S Okumura", "year": "1996", "unstructured": "Okumura S, Kondo H, Tsuboi M, Nakayama H, Asamura H, Tsuchiya R, Naruke T (1996) Pulmonary resection for metastatic colorectal cancer: experiences with 159 patients. J Thorac Cardiovasc Surg 112: 867\u2013874", "journal-title": "J Thorac Cardiovasc Surg"}, {"key": "BF6601619_CR28", "doi-asserted-by": "publisher", "first-page": "135", "DOI": "10.1007/s005990050079", "volume": "29", "author": "S Pedrinaci", "year": "1999", "unstructured": "Pedrinaci S, Algarra I, Garrido F (1999) Protein-bound polysaccharide (PSK) induces cytotoxic activity in the NKL human natural killer cell line. Int J Clin Lab Res 29: 135\u2013140", "journal-title": "Int J Clin Lab Res"}, {"key": "BF6601619_CR29", "doi-asserted-by": "publisher", "first-page": "1787", "DOI": "10.1200/JCO.2001.19.6.1787", "volume": "19", "author": "R Porschen", "year": "2001", "unstructured": "Porschen R, Bermann A, Loffler T, Haack G, Rettig K, Anger Y, Strohmeyer G (2001) Fluorouracil plus leucovorin as effective adjuvant chemotherapy in curatively resected stage III colon cancer: results of the trial adjCCA-01. J Clin Oncol 19: 1787\u20131794", "journal-title": "J Clin Oncol"}, {"key": "BF6601619_CR30", "unstructured": "QUASAR (2000) Comparison of fluorouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer: a randomised trial. QUASAR Collaborative Group. Lancet 355: 1588\u20131596", "DOI": "10.1016/S0140-6736(00)02214-5", "doi-asserted-by": "crossref"}, {"key": "BF6601619_CR31", "doi-asserted-by": "publisher", "first-page": "7", "DOI": "10.1159/000227738", "volume": "54", "author": "YM Rustum", "year": "1997", "unstructured": "Rustum YM (1997) Mechanism-based improvement in the therapeutic selectivity of 5-FU prodrug alone and under conditions of metabolic modulation. Oncology 54: 7\u201311", "journal-title": "Oncology"}, {"key": "BF6601619_CR32", "doi-asserted-by": "publisher", "first-page": "2206", "DOI": "10.1002/(SICI)1097-0142(19960601)77:11<2206::AID-CNCR4>3.0.CO;2-N", "volume": "77", "author": "J Sakamoto", "year": "1996", "unstructured": "Sakamoto J, Teramukai S, Koike A, Saji S, Ohashi Y, Nakazato H (1996) Prognostic value of preoperative immunosuppressive acidic protein in patients with gastric carcinoma. Findings from three independent clinical trials. Tumor Marker Committee for the Study Group of Immunochemotherapy with PSK for Gastric Cancer. Cancer 77: 2206\u20132212", "journal-title": "Cancer"}, {"key": "BF6601619_CR33", "doi-asserted-by": "publisher", "first-page": "905", "DOI": "10.1056/NEJM200009283431302", "volume": "343", "author": "LB Saltz", "year": "2000", "unstructured": "Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ, Maroun JA, Ackland SP, Locker PK, Pirotta N, Elfring GL, Miller LL (2000) Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 343: 905\u2013914", "journal-title": "N Engl J Med"}, {"key": "BF6601619_CR34", "doi-asserted-by": "publisher", "first-page": "782", "DOI": "10.1002/1097-0142(19950201)75:3<782::AID-CNCR2820750306>3.0.CO;2-I", "volume": "75", "author": "LB Saltz", "year": "1995", "unstructured": "Saltz LB, Leichman CG, Young CW, Muggia FM, Conti JA, Spiess T, Jeffers S, Leichman LP (1995) A fixed-ratio combination of uracil and Ftorafur (UFT) with low dose leucovorin. An active oral regimen for advanced colorectal cancer. Cancer 75: 782\u2013785", "journal-title": "Cancer"}, {"key": "BF6601619_CR35", "first-page": "3244", "volume": "41", "author": "K Tamura", "year": "1981", "unstructured": "Tamura K, Shibata Y, Matsuda Y, Ishida N (1981) Isolation and characterization of an immunosuppressive acidic protein from ascitic fluids of cancer patients. Cancer Res 41: 3244\u20133252", "journal-title": "Cancer Res"}, {"key": "BF6601619_CR36", "unstructured": "Tomizawa N, Ohwada S, Tanahashi Y, Ogawa T, Toru K, Izumi T, Ikeya T, Morishita Y (in press) Prognostic factors after anatomical hepatectomy for liver metastases from colorectal cancer. Hepatogastroenterology, not published"}, {"key": "BF6601619_CR37", "doi-asserted-by": "publisher", "first-page": "261", "DOI": "10.1007/BF01740932", "volume": "31", "author": "M Torisu", "year": "1990", "unstructured": "Torisu M, Hayashi Y, Ishimitsu T, Fujimura T, Iwasaki K, Katano M, Yamamoto H, Kimura Y, Takesue M, Kondo M, Nomoto K (1990) Significant prolongation of disease-free period gained by oral polysaccharide K (PSK) administration after curative surgical operation of colorectal cancer. Cancer Immunol Immunother 31: 261\u2013268", "journal-title": "Cancer Immunol Immunother"}, {"key": "BF6601619_CR38", "doi-asserted-by": "publisher", "first-page": "345", "DOI": "10.1016/S0140-6736(98)07186-4", "volume": "353", "author": "JB Vermorken", "year": "1999", "unstructured": "Vermorken JB, Claessen AM, van Tinteren H, Gall HE, Ezinga R, Meijer S, Scheper RJ, Meijer CJ, Bloemena E, Ransom JH, Hanna MG, Jr, Pinedo HM (1999) Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial. Lancet 353: 345\u2013350", "journal-title": "Lancet"}, {"key": "BF6601619_CR39", "doi-asserted-by": "publisher", "first-page": "389", "DOI": "10.1007/BF01526559", "volume": "41", "author": "E Yefenof", "year": "1995", "unstructured": "Yefenof E, Gafanovitch I, Oron E, Bar M, Klein E (1995) Prophylactic intervention in radiation-leukemia-virus-induced murine lymphoma by the biological response modifier polysaccharide K. Cancer Immunol Immunother 41: 389\u2013396", "journal-title": "Cancer Immunol Immunother"}, {"key": "BF6601619_CR40", "doi-asserted-by": "publisher", "first-page": "42", "DOI": "10.1093/oxfordjournals.annonc.a010475", "volume": "7", "author": "JR Zalcberg", "year": "1996", "unstructured": "Zalcberg JR, Siderov J, Simes J (1996) The role of 5-fluorouracil dose in the adjuvant therapy of colorectal cancer. Ann Oncol 7: 42\u201346", "journal-title": "Ann Oncol"}, {"key": "BF6601619_CR41", "first-page": "343", "volume": "18", "author": "H Zhang", "year": "2000", "unstructured": "Zhang H, Morisaki T, Matsunaga H, Sato N, Uchiyama A, Hashizume K, Nagumo F, Tadano J, Katano M (2000) Protein-bound polysaccharide PSK inhibits tumor invasiveness by down-regulation of TGF-beta1 and MMPs. Clin Exp Metastasis 18: 343\u2013352", "journal-title": "Clin Exp Metastasis"}], "container-title": ["British Journal of Cancer"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/6601619.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/6601619", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/6601619.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 16]], "date-time": "2019-03-16T21:40:05Z", "timestamp": 1552772405000}, "score": 44.292503, "issued": {"date-parts": [[2004, 3]]}, "references-count": 41, "journal-issue": {"published-print": {"date-parts": [[2004, 3]]}, "issue": "5"}, "alternative-id": ["BF6601619"], "URL": "http://dx.doi.org/10.1038/sj.bjc.6601619", "relation": {"cites": []}, "ISSN": ["0007-0920", "1532-1827"], "issn-type": [{"value": "0007-0920", "type": "print"}, {"value": "1532-1827", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T04:15:19Z", "timestamp": 1574136919604}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1999, 9, 1]], "date-time": "1999-09-01T00:00:00Z", "timestamp": 936144000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Journal of Cancer"], "published-print": {"date-parts": [[1999, 9]]}, "DOI": "10.1016/s0959-8049(99)80680-7", "type": "journal-article", "created": {"date-parts": [[2002, 10, 16]], "date-time": "2002-10-16T14:35:53Z", "timestamp": 1034778953000}, "page": "S78", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Oral uracil/tegafur (UFT) plus leucovorin (LV) in patients with metastatic colorectal cancer (CRC)"], "prefix": "10.1016", "volume": "35", "author": [{"given": "E.", "family": "Goker", "sequence": "first", "affiliation": []}, {"given": "N.F.", "family": "Aykan", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Serdengecti", "sequence": "additional", "affiliation": []}, {"given": "N.", "family": "Gunel", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Alakavuklar", "sequence": "additional", "affiliation": []}, {"given": "F.", "family": "Icli", "sequence": "additional", "affiliation": []}, {"given": "I.", "family": "Yucel", "sequence": "additional", "affiliation": []}, {"given": "N.", "family": "Uskent", "sequence": "additional", "affiliation": []}, {"given": "F.", "family": "Arpaci", "sequence": "additional", "affiliation": []}, {"given": "D.", "family": "Firat", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Journal of Cancer"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0959804999806807?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0959804999806807?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 8]], "date-time": "2019-04-08T06:50:48Z", "timestamp": 1554706248000}, "score": 43.24525, "issued": {"date-parts": [[1999, 9]]}, "references-count": 0, "alternative-id": ["S0959804999806807"], "URL": "http://dx.doi.org/10.1016/s0959-8049(99)80680-7", "ISSN": ["0959-8049"], "issn-type": [{"value": "0959-8049", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T21:21:27Z", "timestamp": 1576790487486}, "reference-count": 30, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "17", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2004, 9, 1]]}, "abstract": "<jats:sec><jats:title>Purpose</jats:title><jats:p> To compare the efficacy, toxicities, and pharmacokinetics of an oral regimen consisting of uracil/tegafur (UFT) and leucovorin (LV) between Japanese patients and patients in the United States with previously untreated metastatic colorectal cancer. </jats:p></jats:sec><jats:sec><jats:title>Patients and Methods</jats:title><jats:p> Forty-four Japanese patients and 45 patients in the United States were enrolled in concurrent nonrandomized phase II trials. UFT 300 mg/m<jats:sup>2</jats:sup>/d and leucovorin 75 mg/d were administered orally for 28 days followed by a 7-day rest period. The total daily dose of each drug was divided into three equal doses. Treatment was repeated every 5 weeks until disease progression. Blood samples for the pharmacokinetic study were obtained after the initial dose on day 1 of the first course. </jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p> The response rate for the Japanese patients and the patients in the United States was 36.4% (95% CI, 22.4% to 52.2%) and 34.1% (95% CI, 20.5% to 49.9%), respectively. The only major toxicity was diarrhea, and other toxicities were mild in both populations. The incidence of grade 3 or higher diarrhea in the Japanese and Americans was 9% and 22%, respectively. Although the area under the curve and maximum concentration of fluorouracil were found to be slightly higher in the Japanese patients than the patients in the United States, and area under the curve\u2013adjusted body surface area appeared to be comparable between the two groups. </jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p> The efficacy and pharmacokinetic parameters of UFT and LV are comparable in Japanese and American patients; however, a difference in toxicity profile, specifically diarrhea, was noted. This oral regimen of UFT and LV is considered to have similar activity against metastatic colorectal cancer and to have acceptable toxicity in patients in both countries. </jats:p></jats:sec>", "DOI": "10.1200/jco.2004.05.017", "type": "journal-article", "created": {"date-parts": [[2004, 7, 27]], "date-time": "2004-07-27T00:25:05Z", "timestamp": 1090887905000}, "page": "3466-3474", "source": "Crossref", "is-referenced-by-count": 66, "title": ["Comparison of the Efficacy, Toxicity, and Pharmacokinetics of a Uracil/Tegafur (UFT) Plus Oral Leucovorin (LV) Regimen Between Japanese and American Patients With Advanced Colorectal Cancer: Joint United States and Japan Study of UFT/LV"], "prefix": "10.1200", "volume": "22", "author": [{"given": "K.", "family": "Shirao", "sequence": "first", "affiliation": [{"name": "From the Division of Gastrointestinal Oncology, National Cancer Center Hospital, Tokyo; Division of Gastrointestinal Oncology/Digestive Endoscopy, National Cancer Center Hospital East, Chiba; Department of Internal Medicine, National Shikoku Cancer Center, Ehime, Japan; Division of Hematology & Medical Oncology, Department of Medicine, Weill Medical College of Cornell University, Ithaca, NY; Oncology Section, Department of Veterans Affairs Medical Center, Washington, DC; Abramson Cancer Center,..."}]}, {"given": "P.M.", "family": "Hoff", "sequence": "additional", "affiliation": [{"name": "From the Division of Gastrointestinal Oncology, National Cancer Center Hospital, Tokyo; Division of Gastrointestinal Oncology/Digestive Endoscopy, National Cancer Center Hospital East, Chiba; Department of Internal Medicine, National Shikoku Cancer Center, Ehime, Japan; Division of Hematology & Medical Oncology, Department of Medicine, Weill Medical College of Cornell University, Ithaca, NY; Oncology Section, Department of Veterans Affairs Medical Center, Washington, DC; Abramson Cancer Center,..."}]}, {"given": "A.", "family": "Ohtsu", "sequence": "additional", "affiliation": [{"name": "From the Division of Gastrointestinal Oncology, National Cancer Center Hospital, Tokyo; Division of Gastrointestinal Oncology/Digestive Endoscopy, National Cancer Center Hospital East, Chiba; Department of Internal Medicine, National Shikoku Cancer Center, Ehime, Japan; Division of Hematology & Medical Oncology, Department of Medicine, Weill Medical College of Cornell University, Ithaca, NY; Oncology Section, Department of Veterans Affairs Medical Center, Washington, DC; Abramson Cancer Center,..."}]}, {"given": "P.J.", "family": "Loehrer", "sequence": "additional", "affiliation": [{"name": "From the Division of Gastrointestinal Oncology, National Cancer Center Hospital, Tokyo; Division of Gastrointestinal Oncology/Digestive Endoscopy, National Cancer Center Hospital East, Chiba; Department of Internal Medicine, National Shikoku Cancer Center, Ehime, Japan; Division of Hematology & Medical Oncology, Department of Medicine, Weill Medical College of Cornell University, Ithaca, NY; Oncology Section, Department of Veterans Affairs Medical Center, Washington, DC; Abramson Cancer Center,..."}]}, {"given": "I.", "family": "Hyodo", "sequence": "additional", "affiliation": [{"name": "From the Division of Gastrointestinal Oncology, National Cancer Center Hospital, Tokyo; Division of Gastrointestinal Oncology/Digestive Endoscopy, National Cancer Center Hospital East, Chiba; Department of Internal Medicine, National Shikoku Cancer Center, Ehime, Japan; Division of Hematology & Medical Oncology, Department of Medicine, Weill Medical College of Cornell University, Ithaca, NY; Oncology Section, Department of Veterans Affairs Medical Center, Washington, DC; Abramson Cancer Center,..."}]}, {"given": "S.", "family": "Wadler", "sequence": "additional", "affiliation": [{"name": "From the Division of Gastrointestinal Oncology, National Cancer Center Hospital, Tokyo; Division of Gastrointestinal Oncology/Digestive Endoscopy, National Cancer Center Hospital East, Chiba; Department of Internal Medicine, National Shikoku Cancer Center, Ehime, Japan; Division of Hematology & Medical Oncology, Department of Medicine, Weill Medical College of Cornell University, Ithaca, NY; Oncology Section, Department of Veterans Affairs Medical Center, Washington, DC; Abramson Cancer Center,..."}]}, {"given": "R.G.", "family": "Wadleigh", "sequence": "additional", "affiliation": [{"name": "From the Division of Gastrointestinal Oncology, National Cancer Center Hospital, Tokyo; Division of Gastrointestinal Oncology/Digestive Endoscopy, National Cancer Center Hospital East, Chiba; Department of Internal Medicine, National Shikoku Cancer Center, Ehime, Japan; Division of Hematology & Medical Oncology, Department of Medicine, Weill Medical College of Cornell University, Ithaca, NY; Oncology Section, Department of Veterans Affairs Medical Center, Washington, DC; Abramson Cancer Center,..."}]}, {"given": "P.J.", "family": "O'Dwyer", "sequence": "additional", "affiliation": [{"name": "From the Division of Gastrointestinal Oncology, National Cancer Center Hospital, Tokyo; Division of Gastrointestinal Oncology/Digestive Endoscopy, National Cancer Center Hospital East, Chiba; Department of Internal Medicine, National Shikoku Cancer Center, Ehime, Japan; Division of Hematology & Medical Oncology, Department of Medicine, Weill Medical College of Cornell University, Ithaca, NY; Oncology Section, Department of Veterans Affairs Medical Center, Washington, DC; Abramson Cancer Center,..."}]}, {"given": "K.", "family": "Muro", "sequence": "additional", "affiliation": [{"name": "From the Division of Gastrointestinal Oncology, National Cancer Center Hospital, Tokyo; Division of Gastrointestinal Oncology/Digestive Endoscopy, National Cancer Center Hospital East, Chiba; Department of Internal Medicine, National Shikoku Cancer Center, Ehime, Japan; Division of Hematology & Medical Oncology, Department of Medicine, Weill Medical College of Cornell University, Ithaca, NY; Oncology Section, Department of Veterans Affairs Medical Center, Washington, DC; Abramson Cancer Center,..."}]}, {"given": "Y.", "family": "Yamada", "sequence": "additional", "affiliation": [{"name": "From the Division of Gastrointestinal Oncology, National Cancer Center Hospital, Tokyo; Division of Gastrointestinal Oncology/Digestive Endoscopy, National Cancer Center Hospital East, Chiba; Department of Internal Medicine, National Shikoku Cancer Center, Ehime, Japan; Division of Hematology & Medical Oncology, Department of Medicine, Weill Medical College of Cornell University, Ithaca, NY; Oncology Section, Department of Veterans Affairs Medical Center, Washington, DC; Abramson Cancer Center,..."}]}, {"given": "N.", "family": "Boku", "sequence": "additional", "affiliation": [{"name": "From the Division of Gastrointestinal Oncology, National Cancer Center Hospital, Tokyo; Division of Gastrointestinal Oncology/Digestive Endoscopy, National Cancer Center Hospital East, Chiba; Department of Internal Medicine, National Shikoku Cancer Center, Ehime, Japan; Division of Hematology & Medical Oncology, Department of Medicine, Weill Medical College of Cornell University, Ithaca, NY; Oncology Section, Department of Veterans Affairs Medical Center, Washington, DC; Abramson Cancer Center,..."}]}, {"given": "F.", "family": "Nagashima", "sequence": "additional", "affiliation": [{"name": "From the Division of Gastrointestinal Oncology, National Cancer Center Hospital, Tokyo; Division of Gastrointestinal Oncology/Digestive Endoscopy, National Cancer Center Hospital East, Chiba; Department of Internal Medicine, National Shikoku Cancer Center, Ehime, Japan; Division of Hematology & Medical Oncology, Department of Medicine, Weill Medical College of Cornell University, Ithaca, NY; Oncology Section, Department of Veterans Affairs Medical Center, Washington, DC; Abramson Cancer Center,..."}]}, {"given": "J.L.", "family": "Abbruzzese", "sequence": "additional", "affiliation": [{"name": "From the Division of Gastrointestinal Oncology, National Cancer Center Hospital, Tokyo; Division of Gastrointestinal Oncology/Digestive Endoscopy, National Cancer Center Hospital East, Chiba; Department of Internal Medicine, National Shikoku Cancer Center, Ehime, Japan; Division of Hematology & Medical Oncology, Department of Medicine, Weill Medical College of Cornell University, Ithaca, NY; Oncology Section, Department of Veterans Affairs Medical Center, Washington, DC; Abramson Cancer Center,..."}]}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2004.05.017", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T20:12:49Z", "timestamp": 1574885569000}, "score": 42.362633, "issued": {"date-parts": [[2004, 9, 1]]}, "references-count": 30, "journal-issue": {"published-print": {"date-parts": [[2004, 9, 1]]}, "issue": "17"}, "alternative-id": ["10.1200/JCO.2004.05.017"], "URL": "http://dx.doi.org/10.1200/jco.2004.05.017", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T20:45:52Z", "timestamp": 1574282752159}, "reference-count": 45, "publisher": "Springer Science and Business Media LLC", "issue": "8", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2007, 3, 20]], "date-time": "2007-03-20T00:00:00Z", "timestamp": 1174348800000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Br J Cancer"], "published-print": {"date-parts": [[2007, 4]]}, "DOI": "10.1038/sj.bjc.6603686", "type": "journal-article", "created": {"date-parts": [[2007, 3, 20]], "date-time": "2007-03-20T13:27:52Z", "timestamp": 1174397272000}, "page": "1170-1177", "source": "Crossref", "is-referenced-by-count": 40, "title": ["An individual patient data meta-analysis of adjuvant therapy with uracil\u2013tegafur (UFT) in patients with curatively resected rectal cancer"], "prefix": "10.1038", "volume": "96", "author": [{"given": "J", "family": "Sakamoto", "sequence": "first", "affiliation": []}, {"given": "C", "family": "Hamada", "sequence": "additional", "affiliation": []}, {"given": "S", "family": "Yoshida", "sequence": "additional", "affiliation": []}, {"given": "S", "family": "Kodaira", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Yasutomi", "sequence": "additional", "affiliation": []}, {"given": "T", "family": "Kato", "sequence": "additional", "affiliation": []}, {"given": "K", "family": "Oba", "sequence": "additional", "affiliation": []}, {"given": "H", "family": "Nakazato", "sequence": "additional", "affiliation": []}, {"given": "S", "family": "Saji", "sequence": "additional", "affiliation": []}, {"given": "Y", "family": "Ohashi", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2007, 3, 20]]}, "reference": [{"key": "BF6603686_CR1", "doi-asserted-by": "publisher", "first-page": "896", "DOI": "10.1200/JCO.1992.10.6.896", "volume": "10", "author": "Advanced Colorectal Cancer Meta-Analysis Project", "year": "1992", "unstructured": "Advanced Colorectal Cancer Meta-Analysis Project (1992) Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. J Clin Oncol 10: 896\u2013903", "journal-title": "J Clin Oncol"}, {"key": "BF6603686_CR2", "doi-asserted-by": "publisher", "first-page": "237", "DOI": "10.1093/jjco/hyl014", "volume": "36", "author": "T Akasu", "year": "2006", "unstructured": "Akasu T, Moriya Y, Ohashi Y, Yoshida S, Shirao K, Kodaira S, NSAS-CC Group (2006) Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectal excision with selective lateral pelvic lymphadenectomy: a multicenter randomized controlled trial. Jpn J Clin Oncol 36: 237\u2013244", "journal-title": "Jpn J Clin Oncol"}, {"key": "BF6603686_CR3", "doi-asserted-by": "publisher", "first-page": "2343", "DOI": "10.1056/NEJMoa032709", "volume": "350", "author": "T Andr\u00e9", "year": "2004", "unstructured": "Andr\u00e9 T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, Topham C, Zaninelli M, Clingan P, Bridgewater J, Tabah-Fisch I, de Gramont A (2004) Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC) Investigators. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350: 2343\u20132351", "journal-title": "N Engl J Med"}, {"key": "BF6603686_CR4", "doi-asserted-by": "publisher", "first-page": "2896", "DOI": "10.1200/JCO.2003.10.065", "volume": "21", "author": "T Andr\u00e9", "year": "2003", "unstructured": "Andr\u00e9 T, Colin P, Louvet C, Gamelin E, Bouche O, Achille E, Colbert N, Boaziz C, Piedbois P, Tubiana-Mathieu N, Boutan-Laroze A, Flesch M, Buyse M, de Gramont A (2003) Bi-monthly regimen of 5-fluorouracil and leucovorin (LV5FU2) as adjuvant therapy in stage II and III colon cancer: 4-year results of a randomised trial. J Clin Oncol 21: 2896\u20132903", "journal-title": "J Clin Oncol"}, {"key": "BF6603686_CR5", "doi-asserted-by": "publisher", "first-page": "19", "DOI": "10.3322/canjclin.41.1.19", "volume": "41", "author": "CC Boring", "year": "1991", "unstructured": "Boring CC, Squires TS, Tong T (1991) Cancer statistics. CA Cancer J Clin 41: 19\u201351", "journal-title": "CA Cancer J Clin"}, {"key": "BF6603686_CR6", "doi-asserted-by": "publisher", "first-page": "349", "DOI": "10.1016/S0959-8049(01)00371-9", "volume": "38", "author": "MM Borner", "year": "2002", "unstructured": "Borner MM, Schoffski P, de Wit R, Caponigro F, Comella G, Sulkes A, Greim G, Peters GJ, van der Born K, Wanders J, de Boer RF, Martin C, Fumoleau P (2002) Patient preference and pharmacokinetics of oral modulated UFT vs intravenous fluorouracil leucovorin: a randomised crossover trial in advanced colorectal cancer. Eur J Cancer 38: 349\u2013358", "journal-title": "Eur J Cancer"}, {"issue": "Suppl 1", "key": "BF6603686_CR7", "doi-asserted-by": "publisher", "first-page": "20", "DOI": "10.1016/S0093-7754(01)90247-7", "volume": "28", "author": "M Buyse", "year": "2001", "unstructured": "Buyse M, Piedbois P (2001) Should Dukes' B patients receive adjuvant chemotherapy? A statistical perspective. Seminars Oncol 28 (Suppl 1): 20\u201324", "journal-title": "Seminars Oncol"}, {"key": "BF6603686_CR8", "doi-asserted-by": "publisher", "first-page": "3617", "DOI": "10.1200/JCO.2002.10.129", "volume": "20", "author": "J Carmichael", "year": "2002", "unstructured": "Carmichael J, Popiela T, Radstone D, Falk S, Borner M, Oza A, Skovsgaard T, Munier S, Martin C (2002) Randomized comparative study of tegafur/uracil and oral leucovorin vs parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 20: 3617\u20133627", "journal-title": "J Clin Oncol"}, {"key": "BF6603686_CR9", "doi-asserted-by": "publisher", "first-page": "1291", "DOI": "10.1016/S0140-6736(01)06409-1", "volume": "358", "author": "Colorectal Cancer Collaborative Group", "year": "2001", "unstructured": "Colorectal Cancer Collaborative Group (2001) Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients form 22 randomised trials. Lancet 358: 1291\u20131304", "journal-title": "Lancet"}, {"key": "BF6603686_CR10", "first-page": "195", "volume": "28", "author": "M Danno", "year": "2001", "unstructured": "Danno M, Shiroto H, Kunii Y, Ishibiki K, Yamamura Y, Sakamoto Y, Tamura Y, Kunitomo K, Kumashiro R (2001) Study on the intensity of MMC and UFT in postoperative adjuvant chemotherapy for gastric cancer-study report of JFMTC Study No. 10. Jpn J Cancer Chemother 28: 195\u2013203", "journal-title": "Jpn J Cancer Chemother"}, {"key": "BF6603686_CR11", "doi-asserted-by": "publisher", "first-page": "808", "DOI": "10.1200/JCO.1997.15.2.808", "volume": "15", "author": "A de Gramont", "year": "1997", "unstructured": "de Gramont A, Bosset JF, Milan C, Rougier P, Bouche O, Etienne PL, Morvan F, Louvet C, Guillot T, Francois E, Bedenne L (1997) Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer. J Clin Oncol 15: 808\u2013815", "journal-title": "J Clin Oncol"}, {"key": "BF6603686_CR12", "first-page": "17", "volume": "13", "author": "RB Diasio", "year": "1999", "unstructured": "Diasio RB (1999) Clinical implications of dihydropyrimidine dehydrogenase inhibition. Oncology 13: 17\u201321", "journal-title": "Oncology"}, {"key": "BF6603686_CR13", "doi-asserted-by": "publisher", "first-page": "3605", "DOI": "10.1200/JCO.2002.04.123", "volume": "20", "author": "JY Douillard", "year": "2002", "unstructured": "Douillard JY, Hoff PM, Skillings JR, Eisenberg P, Davidson N, Harper P, Vincent MD, Lembersky BC, Thompson S, Maniero A, Benner SE (2002) Multicenter phase III study of uracil/tegafur and oral leucovorin vs fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 20: 3605\u20133616", "journal-title": "J Clin Oncol"}, {"key": "BF6603686_CR14", "doi-asserted-by": "publisher", "first-page": "21", "DOI": "10.1093/jnci/80.1.21", "volume": "80", "author": "B Fisher", "year": "1988", "unstructured": "Fisher B, Wolmark N, Rockette H, Redmond C, Deutsch M, Wickerham DL, Fisher ER, Caplan R, Jones J, Lerner H, Gordon P, Feldman M, Cruz A, Legault-Poisson S, Wexler M, Lawrence W, Robidoux A, Other NSABP Investigators (1988) Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst 80: 21\u201329", "journal-title": "J Natl Cancer Inst"}, {"key": "BF6603686_CR15", "first-page": "2735", "volume": "14", "author": "H Fukunaga", "year": "1987", "unstructured": "Fukunaga H, Katsumi M, Aoki Y, Oka S, Konishi R, Yukawa H, Kawaguchi T, Tamaki Y, Takifuji K (1987) 5-FU concentration in tumor tissue and the antitumor effect in patients with gastric cancer after oral administration of UFT. Jpn J Cancer Chemother 14: 2735\u20132739 (in Japanese)", "journal-title": "Jpn J Cancer Chemother"}, {"key": "BF6603686_CR16", "first-page": "246", "volume": "23", "author": "RG Gray", "year": "2004", "unstructured": "Gray RG, Barnwell J, Hills R, McConkey C, Williams N, Kerr D, for the QUASAR Collaborative Group (2004) QUASAR: A randomized study of adjuvant chemotherapy (CT) vs observation including 3238 colorectal cancer patients. Proc Am Soc Clin Oncol 23: 246 (abstr 3501)", "journal-title": "Proc Am Soc Clin Oncol"}, {"key": "BF6603686_CR17", "doi-asserted-by": "publisher", "first-page": "2282", "DOI": "10.1200/JCO.2001.19.8.2282", "volume": "19", "author": "PM Hoff", "year": "2001", "unstructured": "Hoff PM, Ansari R, Batist G, Cox J, Kocha W, Kuperminc M, Maroun J, Walde D, Weaver C, Harrison E, Burger HU, Osterwalder B, Wong AO, Wong R (2001) Comparison of oral capecitabine vs intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. J Clin Oncol 19: 2282\u20132292", "journal-title": "J Clin Oncol"}, {"key": "BF6603686_CR18", "doi-asserted-by": "publisher", "first-page": "939", "DOI": "10.1016/S0140-6736(95)90696-7", "volume": "345", "author": "International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators", "year": "1995", "unstructured": "International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators (1995) Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 345: 939\u2013944", "journal-title": "Lancet"}, {"key": "BF6603686_CR19", "doi-asserted-by": "publisher", "first-page": "1713", "DOI": "10.1056/NEJMoa032792", "volume": "350", "author": "H Kato", "year": "2004", "unstructured": "Kato H, Ichinose Y, Ohta M, Hata E, Tsubota N, Tada H, Watanabe Y, Wada H, Tsuboi M, Hamajima N, Ohta M, Japan Lung Cancer Research Group on Postsurgical Adjuvant Chemotherapy (2004) A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med 350: 1713\u20131721", "journal-title": "N Engl J Med"}, {"key": "BF6603686_CR20", "doi-asserted-by": "publisher", "first-page": "575", "DOI": "10.1007/s00423-002-0278-x", "volume": "386", "author": "T Kato", "year": "2002", "unstructured": "Kato T, Ohashi Y, Nakazato H, Koike S, Saji S, Suzuki H, Takagi H, Nimura Y, Hasumi A, Baba S, Manabe T, Maruta M, Miura K, Yamaguchi A (2002) Efficacy of oral UFT as adjuvant chemotherapy to curative resection of colorectal cancer: multicenter prospective randomized trial. Langenbecks Arch Surg 386: 575\u2013581", "journal-title": "Langenbecks Arch Surg"}, {"key": "BF6603686_CR21", "first-page": "889", "volume": "71", "author": "Y Kawaguchi", "year": "1980", "unstructured": "Kawaguchi Y, Nagayama S, Masuda H, Yasuda A (1980) Studies on the metabolism of 1-(2-tetrahydrofuryl)-5-fluorouracil and uracil co-administered orally to tumor- bearing rats. Gann 71: 889\u2013899", "journal-title": "Gann"}, {"key": "BF6603686_CR22", "first-page": "313s", "volume": "23S", "author": "T Kinoshita", "year": "2005", "unstructured": "Kinoshita T, Nakajima T, Ohashi Y, National Surgical Adjuvant Study Group of Gastric Cancer (2005) Survival benefit of adjuvant chemotherapy with Uracil-tegafur (UFT) for serosa negative advanced gastric cancer (AGC): Results of a randomized trial by National Surgical Adjuvant Study of Gastric Cancer. Proc Am Soc Clin Oncol 23S: 313s (abstr 4021)", "journal-title": "Proc Am Soc Clin Oncol"}, {"key": "BF6603686_CR23", "doi-asserted-by": "publisher", "first-page": "357", "DOI": "10.1007/BF00539213", "volume": "3", "author": "S Kodaira", "year": "1998", "unstructured": "Kodaira S, Kikuchi K, Yasutomi M, Takahashi T, Hojo K, Kato T, Tominaga T, Kunii Y (1998) Postoperative adjuvant chemotherapy with mitomycin C and UFT for curatively resected rectal cancer. Results from the Cooperative Project No. 7 Group of the Japanese Foundation for Multidisciplinary Treatment of Cancer. Int J Clin Oncol 3: 357\u2013364", "journal-title": "Int J Clin Oncol"}, {"key": "BF6603686_CR24", "doi-asserted-by": "publisher", "first-page": "2059", "DOI": "10.1200/JCO.2005.04.7498", "volume": "24", "author": "BC Lembersky", "year": "2006", "unstructured": "Lembersky BC, Wieand HS, Petrelli NJ, O'Connell MJ, Colangelo LH, Smith RE, Seay TE, Giguere JK, Marshall ME, Jacobs AD, Colman LK, Soran A, Yothers G, Wolmark N (2006) Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06. J Clin Oncol 24: 2059\u20132064", "journal-title": "J Clin Oncol"}, {"key": "BF6603686_CR25", "doi-asserted-by": "publisher", "first-page": "1349", "DOI": "10.1200/JCO.1999.17.5.1349", "volume": "17", "author": "E Mamounas", "year": "1999", "unstructured": "Mamounas E, Wieand S, Wolmark N, Bear HD, Atkins JN, Song K, Jones J, Rockette H (1999) Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B vs Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04). J Clin Oncol 17: 1349\u20131355", "journal-title": "J Clin Oncol"}, {"key": "BF6603686_CR26", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1200/JCO.1998.16.1.1", "volume": "16", "author": "Meta-Analysis Group In Cancer", "year": "1998", "unstructured": "Meta-Analysis Group In Cancer (1998a) Toxicity of 5-fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors. J Clin Oncol 16: 1\u20136", "journal-title": "J Clin Oncol"}, {"key": "BF6603686_CR27", "doi-asserted-by": "publisher", "first-page": "301", "DOI": "10.1200/JCO.1998.16.1.301", "volume": "16", "author": "Meta-Analysis Group In Cancer", "year": "1998", "unstructured": "Meta-Analysis Group In Cancer (1998b) Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J Clin Oncol 16: 301\u2013308", "journal-title": "J Clin Oncol"}, {"key": "BF6603686_CR28", "doi-asserted-by": "publisher", "first-page": "1444", "DOI": "10.1001/jama.1990.03450110090034", "volume": "264", "author": "NIH Consensus Conference", "year": "1990", "unstructured": "NIH Consensus Conference (1990) Adjuvant therapy for patients with colon and rectal cancer. JAMA 264: 1444\u20131450", "journal-title": "JAMA"}, {"key": "BF6603686_CR29", "doi-asserted-by": "publisher", "first-page": "2172", "DOI": "10.1200/JCO.2005.02.158", "volume": "23", "author": "S Noguchi", "year": "2005", "unstructured": "Noguchi S, Koyama H, Uchino J, Abe R, Miura S, Sugimachi K, Akazawa K, Abe O (2005) Postoperative adjuvant therapy with tamoxifen, tegafur plus uracil, or both in women with node-negative breast cancer: a pooled analysis of six randomized controlled trials. J Clin Oncol 23: 2172\u20132184", "journal-title": "J Clin Oncol"}, {"key": "BF6603686_CR30", "doi-asserted-by": "publisher", "first-page": "246", "DOI": "10.1200/JCO.1997.15.1.246", "volume": "15", "author": "MJ O'Connell", "year": "1997", "unstructured": "O'Connell MJ, Mailliard JA, Kahn MJ, Macdonald JS, Haller DG, Mayer RJ, Wieand HS (1997) Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol 15: 246\u2013250", "journal-title": "J Clin Oncol"}, {"key": "BF6603686_CR31", "doi-asserted-by": "publisher", "first-page": "1329", "DOI": "10.1248/bpb.24.1329", "volume": "24", "author": "A Ooi", "year": "2001", "unstructured": "Ooi A, Ohkubo T, Higashigawa M, Kawasaki H, Kakito H, Kagawa Y, Kojima M, Sakurai M (2001) Plasma, intestine and tumor levels of 5-fluorouracil in mice bearing L1210 ascites tumor following oral administration of 5-fluorouracil, UFT (mixed compound of tegafur and uracil), carmofur and 5\u2032-deoxy-5-fluorouridine. Biol Pharm Bull 24: 1329\u20131331", "journal-title": "Biol Pharm Bull"}, {"key": "BF6603686_CR32", "doi-asserted-by": "publisher", "first-page": "891", "DOI": "10.1002/ijc.2910550604", "volume": "55", "author": "P Pisani", "year": "1993", "unstructured": "Pisani P, Parkin DM, Ferlay J (1993) Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer 55: 891\u2013903", "journal-title": "Int J Cancer"}, {"key": "BF6603686_CR33", "doi-asserted-by": "publisher", "first-page": "78", "DOI": "10.1093/jjco/29.2.78", "volume": "29", "author": "J Sakamoto", "year": "1999", "unstructured": "Sakamoto J, Hamada C, Kodaira S, Nakazato H, Ohashi Y (1999) Adjuvant therapy with oral fluoropyrimidines as main chemotherapeutic agents after curative resection for colorectal cancer: Individual patient data meta-analysis of randomized trials. Jpn J Clin Oncol 29: 78\u201386", "journal-title": "Jpn J Clin Oncol"}, {"key": "BF6603686_CR34", "doi-asserted-by": "publisher", "first-page": "484", "DOI": "10.1200/jco.2004.22.14_suppl.4142", "volume": "22", "author": "J Sakamoto", "year": "2004", "unstructured": "Sakamoto J, Ohashi Y, Hamada C, Buyse M, Burzykowski T, Piedbois P (2004) Meta-Analysis Group of the Japanese Society for Cancer of the Colon and Recum; Meta-Analysis Group in Cancer. Efficacy of oral adjuvant therapy after resection of colorectal cancer: 5-year results from three randomized trials. J Clin Oncol 22: 484\u2013492", "journal-title": "J Clin Oncol"}, {"key": "BF6603686_CR35", "doi-asserted-by": "publisher", "first-page": "1731", "DOI": "10.1056/NEJMoa040694", "volume": "351", "author": "R Sauer", "year": "2004", "unstructured": "Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidgerger H, Raab R, German Rectal Cancer Study Group (2004) Preoperative vs postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351: 1731\u20131740", "journal-title": "N Engl J Med"}, {"key": "BF6603686_CR36", "first-page": "241a", "volume": "19", "author": "HJ Schmoll", "year": "2000", "unstructured": "Schmoll HJ, K\u00f6hne CH, Lorenz M, Sch\u00f6ffski P, Voigtmann R, Bokemeyer C, Lutz MP, Kleeberg U, Ridwelski K, Souchon R, El-Sarafi M, Weiss U, Couvreur ML, Baron B, Wils JA (2000) Weekly 24\u2009h infusion of high-dose (HD) 5-fluorouracil (5-FU24\u2009h) with or without folinic acid (FA) vs bolus 5-FU/FA (NCCTG/Mayo) in advanced colorectal cancer (CRC): a randomized phase III study of the EORTC GITCCG and the AIO. Proc Am Soc Clin Oncol 19: 241a (abstr 935)", "journal-title": "Proc Am Soc Clin Oncol"}, {"key": "BF6603686_CR37", "unstructured": "Statistics and information department, Ministry of Health and Welfare (1996) Deaths and death rates by sex and causes of death: Japan 1995 and 1994. In: Vital Stastics of Japan, vol 1, p 465. Health and Welfare Statistics Association: Tokyo"}, {"key": "BF6603686_CR38", "doi-asserted-by": "publisher", "first-page": "233", "DOI": "10.1007/s002800050652", "volume": "40", "author": "K Sugimachi", "year": "1997", "unstructured": "Sugimachi K, Maehara Y, Ogawa M, Kakegawa T, Tomita M (1997) Dose intensity of uracil and tegafur in postoperative chemotherapy for patients with poorly differentiated gastric cancer. Cancer Chemother Pharmacol 40: 233\u2013238", "journal-title": "Cancer Chemother Pharmacol"}, {"key": "BF6603686_CR39", "doi-asserted-by": "publisher", "first-page": "980", "DOI": "10.1056/NEJM199704033361402", "volume": "336", "author": "Swedish Rectal Cancer Trial", "year": "1997", "unstructured": "Swedish Rectal Cancer Trial (1997) Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 336: 980\u2013987", "journal-title": "N Engl J Med"}, {"key": "BF6603686_CR40", "doi-asserted-by": "publisher", "first-page": "4097", "DOI": "10.1200/JCO.2001.19.21.4097", "volume": "19", "author": "E Van Cutsem", "year": "2001", "unstructured": "Van Cutsem E, Twelves C, Cassidy J, Allman D, Bajetta E, Boyer M, Bugat R, Findlay M, Frings S, Jahn M, McKendrick J, Osterwalder B, Perez-Manga G, Rosso R, Rougier P, Schmiegel WH, Seitz JF, Thompson P, Vieitez JM, Weitzel C, Harper P (2001) Oral capecitabine compared with with intravenous 5-fluorouracil plus leucovorin (Mayo Clinic regimen) in patients with metastatic colorectal cancer: results of a large phase III study. J Clin Oncol 19: 4097\u20134106", "journal-title": "J Clin Oncol"}, {"key": "BF6603686_CR41", "doi-asserted-by": "publisher", "first-page": "573", "DOI": "10.1007/BF02050993", "volume": "37", "author": "AM Vernaba", "year": "1994", "unstructured": "Vernaba AM, Longo WE, Virgo KS, Coplin MA, Wade TP, Johnson FE (1994) Current follow up statistics after resection of colorectal cancer. Dis Colon Rectum 37: 573\u2013583", "journal-title": "Dis Colon Rectum"}, {"key": "BF6603686_CR42", "doi-asserted-by": "publisher", "first-page": "98", "DOI": "10.1007/s10147-003-0374-0", "volume": "9", "author": "M Watanabe", "year": "2004", "unstructured": "Watanabe M, Nishida O, Kunii Y, Kodaira S, Takahashi T, Tominaga T, Hojyo K, Kato T, Niimoto M, Kunitomo K, Isomoto H, Ohashi Y, Yasutomi M (2004) Randomized controlled trial of the efficacy of adjuvant immunochemotherapy and adjuvant chemotherapy for colorectal cancer, using different combinations of the intracutaneous streptococcal preparation OK-432 and the oral pyrimidines 1-hexylcarbamoyl-5-fluorouracil and uracil/tegafur. Int J Clin Oncol 9: 98\u2013106", "journal-title": "Int J Clin Oncol"}, {"key": "BF6603686_CR43", "doi-asserted-by": "publisher", "first-page": "1879", "DOI": "10.1200/JCO.1993.11.10.1879", "volume": "11", "author": "N Wolmark", "year": "1993", "unstructured": "Wolmark N, Rockette H, Fisher B, Wickerham DL, Redmond C, Fisher ER, Jones J, Mamounas EP, L Ore L, Petrelli NJ (1993) The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-03. J Clin Oncol 11: 1879\u20131887", "journal-title": "J Clin Oncol"}, {"key": "BF6603686_CR44", "doi-asserted-by": "publisher", "first-page": "3553", "DOI": "10.1200/JCO.1999.17.11.3553", "volume": "17", "author": "N Wolmark", "year": "1999", "unstructured": "Wolmark N, Rockette H, Mamounas E, Jones J, Wieand S, Wickerham DL, Bear HD, Atkins JN, Dimitrov NV, Glass AG, Fisher ER, Fisher B (1999) Clinical trial to assess the relative efficacy of fluorouracil and leucovolin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes'B and C carcinoma of the colon : Results from national surgical adjuvant breast and bowel project C-04. J Clin Oncol 17: 3553\u20133559", "journal-title": "J Clin Oncol"}, {"key": "BF6603686_CR45", "doi-asserted-by": "publisher", "first-page": "388", "DOI": "10.1093/jnci/92.5.388", "volume": "92", "author": "N Wolmark", "year": "2000", "unstructured": "Wolmark N, Wieand HS, Hyams DM, Colangelo L, Dimitrov NV, Romond EH, Wexler M, Prager D, Cruz Jr AB, Gordon PH, Petrelli NJ, Deutsch M, Mamounas E, Wickerham DL, Fisher ER, Rockette H, Fisher B (2000) Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst 92: 388\u2013396", "journal-title": "J Natl Cancer Inst"}], "container-title": ["British Journal of Cancer"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/6603686.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/6603686", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/6603686.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 15]], "date-time": "2019-04-15T07:12:30Z", "timestamp": 1555312350000}, "score": 41.48989, "issued": {"date-parts": [[2007, 3, 20]]}, "references-count": 45, "journal-issue": {"published-print": {"date-parts": [[2007, 4]]}, "issue": "8"}, "alternative-id": ["BF6603686"], "URL": "http://dx.doi.org/10.1038/sj.bjc.6603686", "relation": {"cites": []}, "ISSN": ["0007-0920", "1532-1827"], "issn-type": [{"value": "0007-0920", "type": "print"}, {"value": "1532-1827", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T23:54:57Z", "timestamp": 1576799697081}, "reference-count": 0, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "14_suppl", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2004, 7, 15]]}, "DOI": "10.1200/jco.2004.22.14_suppl.3681", "type": "journal-article", "created": {"date-parts": [[2017, 4, 5]], "date-time": "2017-04-05T08:02:15Z", "timestamp": 1491379335000}, "page": "3681-3681", "source": "Crossref", "is-referenced-by-count": 1, "title": ["A phase II trial of oxaliplatin (L-OHP) and uracil-tegafur (UFT)/folinic acid (FA) for advanced colorectal cancer (ACC) in elderly patients"], "prefix": "10.1200", "volume": "22", "author": [{"given": "G.", "family": "Rosati", "sequence": "first", "affiliation": [{"name": "San Carlo Hospital, Potenza, Italy; San Luigi Hospital, Catania, Italy; Civil Hospital, Nola, Italy; Data Management Unit, Medi Service, Genova, Italy"}]}, {"given": "S.", "family": "Cordio", "sequence": "additional", "affiliation": [{"name": "San Carlo Hospital, Potenza, Italy; San Luigi Hospital, Catania, Italy; Civil Hospital, Nola, Italy; Data Management Unit, Medi Service, Genova, Italy"}]}, {"given": "A.", "family": "Tucci", "sequence": "additional", "affiliation": [{"name": "San Carlo Hospital, Potenza, Italy; San Luigi Hospital, Catania, Italy; Civil Hospital, Nola, Italy; Data Management Unit, Medi Service, Genova, Italy"}]}, {"given": "G.", "family": "Blanco", "sequence": "additional", "affiliation": [{"name": "San Carlo Hospital, Potenza, Italy; San Luigi Hospital, Catania, Italy; Civil Hospital, Nola, Italy; Data Management Unit, Medi Service, Genova, Italy"}]}, {"given": "R.", "family": "Bordonaro", "sequence": "additional", "affiliation": [{"name": "San Carlo Hospital, Potenza, Italy; San Luigi Hospital, Catania, Italy; Civil Hospital, Nola, Italy; Data Management Unit, Medi Service, Genova, Italy"}]}, {"given": "C.", "family": "Pizza", "sequence": "additional", "affiliation": [{"name": "San Carlo Hospital, Potenza, Italy; San Luigi Hospital, Catania, Italy; Civil Hospital, Nola, Italy; Data Management Unit, Medi Service, Genova, Italy"}]}, {"given": "G.", "family": "Reggiardo", "sequence": "additional", "affiliation": [{"name": "San Carlo Hospital, Potenza, Italy; San Luigi Hospital, Catania, Italy; Civil Hospital, Nola, Italy; Data Management Unit, Medi Service, Genova, Italy"}]}, {"given": "L.", "family": "Manzione", "sequence": "additional", "affiliation": [{"name": "San Carlo Hospital, Potenza, Italy; San Luigi Hospital, Catania, Italy; Civil Hospital, Nola, Italy; Data Management Unit, Medi Service, Genova, Italy"}]}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/jco.2004.22.14_suppl.3681", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T21:55:33Z", "timestamp": 1574891733000}, "score": 40.643196, "issued": {"date-parts": [[2004, 7, 15]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2004, 7, 15]]}, "issue": "14_suppl"}, "alternative-id": ["10.1200/jco.2004.22.14_suppl.3681"], "URL": "http://dx.doi.org/10.1200/jco.2004.22.14_suppl.3681", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T23:56:01Z", "timestamp": 1576799761293}, "reference-count": 0, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "14_suppl", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2004, 7, 15]]}, "DOI": "10.1200/jco.2004.22.90140.3681", "type": "journal-article", "created": {"date-parts": [[2017, 4, 5]], "date-time": "2017-04-05T07:17:42Z", "timestamp": 1491376662000}, "page": "3681-3681", "source": "Crossref", "is-referenced-by-count": 0, "title": ["A phase II trial of oxaliplatin (L-OHP) and uracil-tegafur (UFT)/folinic acid (FA) for advanced colorectal cancer (ACC) in elderly patients"], "prefix": "10.1200", "volume": "22", "author": [{"given": "G.", "family": "Rosati", "sequence": "first", "affiliation": [{"name": "San Carlo Hospital, Potenza, Italy; San Luigi Hospital, Catania, Italy; Civil Hospital, Nola, Italy; Data Management Unit, Medi Service, Genova, Italy"}]}, {"given": "S.", "family": "Cordio", "sequence": "additional", "affiliation": [{"name": "San Carlo Hospital, Potenza, Italy; San Luigi Hospital, Catania, Italy; Civil Hospital, Nola, Italy; Data Management Unit, Medi Service, Genova, Italy"}]}, {"given": "A.", "family": "Tucci", "sequence": "additional", "affiliation": [{"name": "San Carlo Hospital, Potenza, Italy; San Luigi Hospital, Catania, Italy; Civil Hospital, Nola, Italy; Data Management Unit, Medi Service, Genova, Italy"}]}, {"given": "G.", "family": "Blanco", "sequence": "additional", "affiliation": [{"name": "San Carlo Hospital, Potenza, Italy; San Luigi Hospital, Catania, Italy; Civil Hospital, Nola, Italy; Data Management Unit, Medi Service, Genova, Italy"}]}, {"given": "R.", "family": "Bordonaro", "sequence": "additional", "affiliation": [{"name": "San Carlo Hospital, Potenza, Italy; San Luigi Hospital, Catania, Italy; Civil Hospital, Nola, Italy; Data Management Unit, Medi Service, Genova, Italy"}]}, {"given": "C.", "family": "Pizza", "sequence": "additional", "affiliation": [{"name": "San Carlo Hospital, Potenza, Italy; San Luigi Hospital, Catania, Italy; Civil Hospital, Nola, Italy; Data Management Unit, Medi Service, Genova, Italy"}]}, {"given": "G.", "family": "Reggiardo", "sequence": "additional", "affiliation": [{"name": "San Carlo Hospital, Potenza, Italy; San Luigi Hospital, Catania, Italy; Civil Hospital, Nola, Italy; Data Management Unit, Medi Service, Genova, Italy"}]}, {"given": "L.", "family": "Manzione", "sequence": "additional", "affiliation": [{"name": "San Carlo Hospital, Potenza, Italy; San Luigi Hospital, Catania, Italy; Civil Hospital, Nola, Italy; Data Management Unit, Medi Service, Genova, Italy"}]}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/jco.2004.22.90140.3681", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T22:03:33Z", "timestamp": 1574892213000}, "score": 40.643196, "issued": {"date-parts": [[2004, 7, 15]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2004, 7, 15]]}, "issue": "14_suppl"}, "alternative-id": ["10.1200/jco.2004.22.90140.3681"], "URL": "http://dx.doi.org/10.1200/jco.2004.22.90140.3681", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T04:15:31Z", "timestamp": 1574136931650}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1999, 9, 1]], "date-time": "1999-09-01T00:00:00Z", "timestamp": 936144000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Journal of Cancer"], "published-print": {"date-parts": [[1999, 9]]}, "DOI": "10.1016/s0959-8049(99)81478-6", "type": "journal-article", "created": {"date-parts": [[2002, 10, 16]], "date-time": "2002-10-16T14:35:53Z", "timestamp": 1034778953000}, "page": "S266", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Phase I and pharmacokinetic study of irinotecan (CPT-11) given by 24 hours infusion plus oral uracil/tegafur (UFT) in patients with lung cancer"], "prefix": "10.1016", "volume": "35", "author": [{"given": "H.", "family": "Yamazaki", "sequence": "first", "affiliation": []}, {"given": "A.", "family": "Hirano", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Funakoshi", "sequence": "additional", "affiliation": []}, {"given": "Y.", "family": "Kuraishi", "sequence": "additional", "affiliation": []}, {"given": "Y.", "family": "Akiyama", "sequence": "additional", "affiliation": []}, {"given": "T.", "family": "Sato", "sequence": "additional", "affiliation": []}, {"given": "N.", "family": "Mizunuma", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Aiba", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Journal of Cancer"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0959804999814786?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0959804999814786?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 8]], "date-time": "2019-04-08T06:20:32Z", "timestamp": 1554704432000}, "score": 38.722088, "issued": {"date-parts": [[1999, 9]]}, "references-count": 0, "alternative-id": ["S0959804999814786"], "URL": "http://dx.doi.org/10.1016/s0959-8049(99)81478-6", "ISSN": ["0959-8049"], "issn-type": [{"value": "0959-8049", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T19:58:07Z", "timestamp": 1575143887108}, "reference-count": 6, "publisher": "Elsevier BV", "issue": "4", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1997, 1, 1]], "date-time": "1997-01-01T00:00:00Z", "timestamp": 852076800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Oncology"], "published-print": {"date-parts": [[1997, 1]]}, "DOI": "10.1016/s0936-6555(97)80017-9", "type": "journal-article", "created": {"date-parts": [[2005, 4, 16]], "date-time": "2005-04-16T11:28:36Z", "timestamp": 1113650916000}, "page": "269-270", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Life-threatening toxicity of oral tegafur-uracil (UFT) plus leucovorin"], "prefix": "10.1016", "volume": "9", "author": [{"given": "A.", "family": "Ribas", "sequence": "first", "affiliation": []}, {"given": "E.", "family": "Gallardo", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Vera", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Casado", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Vidal", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Bellmunt", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Clinical Oncology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0936655597800179?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0936655597800179?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 13]], "date-time": "2019-02-13T17:43:24Z", "timestamp": 1550079804000}, "score": 38.03436, "issued": {"date-parts": [[1997, 1]]}, "references-count": 6, "journal-issue": {"published-print": {"date-parts": [[1997, 1]]}, "issue": "4"}, "alternative-id": ["S0936655597800179"], "URL": "http://dx.doi.org/10.1016/s0936-6555(97)80017-9", "ISSN": ["0936-6555"], "issn-type": [{"value": "0936-6555", "type": "print"}], "subject": ["Oncology", "Radiology Nuclear Medicine and imaging"]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T06:58:04Z", "timestamp": 1574405884100}, "reference-count": 0, "publisher": "Alphamed Press", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["The Oncologist"], "published-print": {"date-parts": [[2010, 1, 1]]}, "DOI": "10.1634/theoncologist.2009-0255", "type": "journal-article", "created": {"date-parts": [[2010, 1, 16]], "date-time": "2010-01-16T01:35:23Z", "timestamp": 1263605723000}, "page": "26-36", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Therapeutic Usefulness of Postoperative Adjuvant Chemotherapy with Tegafur-Uracil (UFT) in Patients with Breast Cancer: Focus on the Results of Clinical Studies in Japan"], "prefix": "10.1634", "volume": "15", "author": [{"given": "T.", "family": "Nakayama", "sequence": "first", "affiliation": []}, {"given": "S.", "family": "Noguchi", "sequence": "additional", "affiliation": []}], "member": "638", "published-online": {"date-parts": [[2010, 1, 15]]}, "container-title": ["The Oncologist"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1634/theoncologist.2009-0255", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T00:01:50Z", "timestamp": 1482451310000}, "score": 37.73558, "issued": {"date-parts": [[2010, 1, 1]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2010, 1, 29]]}, "published-print": {"date-parts": [[2010, 1, 1]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.1634/theoncologist.2009-0255", "ISSN": ["1083-7159", "1549-490X"], "issn-type": [{"value": "1083-7159", "type": "print"}, {"value": "1549-490X", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T17:23:02Z", "timestamp": 1575307382306}, "reference-count": 52, "publisher": "Springer Science and Business Media LLC", "issue": "8", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2008, 9, 16]], "date-time": "2008-09-16T00:00:00Z", "timestamp": 1221523200000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Br J Cancer"], "published-print": {"date-parts": [[2008, 10]]}, "DOI": "10.1038/sj.bjc.6604666", "type": "journal-article", "created": {"date-parts": [[2008, 9, 16]], "date-time": "2008-09-16T20:54:13Z", "timestamp": 1221598453000}, "page": "1232-1238", "source": "Crossref", "is-referenced-by-count": 9, "title": ["Cost-effectiveness of adjuvant chemotherapy with uracil\u2013tegafur for curatively resected stage III rectal cancer"], "prefix": "10.1038", "volume": "99", "author": [{"given": "A", "family": "Hisashige", "sequence": "first", "affiliation": []}, {"given": "S", "family": "Yoshida", "sequence": "additional", "affiliation": []}, {"given": "S", "family": "Kodaira", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2008, 9, 16]]}, "reference": [{"key": "BF6604666_CR1", "doi-asserted-by": "publisher", "first-page": "1082", "DOI": "10.1002/cncr.22512", "volume": "109", "author": "S Aball\u00e9a", "year": "2007", "unstructured": "Aball\u00e9a S, Chancellor JV, Raikou M, Drummond MF, Weinstein MC, Jourdan S, Bridgewater J (2007) Cost-effectiveness analysis of oxaliplatin compared with 5-fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the US. Cancer 109: 1082\u20131089", "journal-title": "Cancer"}, {"key": "BF6604666_CR2", "doi-asserted-by": "publisher", "first-page": "716", "DOI": "10.1109/TAC.1974.1100705", "volume": "19", "author": "H Akaike", "year": "1974", "unstructured": "Akaike H (1974) A new look at the statistical model identification. IEEE Trans Automat Contr 19: 716\u2013723", "journal-title": "IEEE Trans Automat Contr"}, {"key": "BF6604666_CR3", "author": "T Akasu", "first-page": "667", "year": "1997", "unstructured": "Akasu T, Moriya Y (1997) Abdominopelvic lymphadenectomy with autonomic nerve preservation for carcinoma of the rectum: Japanese experience. In Surgery for Gastrointestinal cancer: a Multi-Disciplinary Approach, Wanebo HJ (ed), pp 667\u2013680. Lippincott-Raven: Philadelphia", "volume-title": "Surgery for Gastrointestinal cancer: a Multi-Disciplinary Approach"}, {"key": "BF6604666_CR4", "doi-asserted-by": "publisher", "first-page": "237", "DOI": "10.1093/jjco/hyl014", "volume": "36", "author": "T Akasu", "year": "2006", "unstructured": "Akasu T, Moriya Y, Ohashi Y, Yoshida S, Shirao K, Kodaira S (2006) Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectal excision with selective lateral pelvic lymphadenectomy: a multicenter randomized controlled trial. Jpn J Clin Oncol 36: 237\u2013244", "journal-title": "Jpn J Clin Oncol"}, {"key": "BF6604666_CR5", "doi-asserted-by": "publisher", "first-page": "2343", "DOI": "10.1056/NEJMoa032709", "volume": "350", "author": "T Andr\u00e9", "year": "2004", "unstructured": "Andr\u00e9 T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, Topham C, Zaninelli M, Clingan P, Bridgewater J, Tabah-Fisch I, de Gramont A (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. NEJM 350: 2343\u20132351", "journal-title": "NEJM"}, {"key": "BF6604666_CR6", "doi-asserted-by": "publisher", "first-page": "439", "DOI": "10.1038/sj.bjc.6603493", "volume": "96", "author": "E Bajetta", "year": "2007", "unstructured": "Bajetta E, Bartolomeo MD, Buzzoni R, Mariani L, Zilembo N, Ferrario E, Vullo SL, Aitini E, Isa L, Barone C, Jacobelli S, Recaldin E, Pinotti G, Iop A on behalf of the ITMO group (2007) Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study. Br J Cancer 96: 439\u2013444", "journal-title": "Br J Cancer"}, {"key": "BF6604666_CR7", "doi-asserted-by": "publisher", "first-page": "69", "DOI": "10.1038/sj.bjc.6602913", "volume": "94", "author": "J Bennouna", "year": "2006", "unstructured": "Bennouna J, Perrier H, Paillot B, Priou F, Jacob JH, Hebbar M, Bordenave S, Seitz JF, Cvitkovic F, Dorval E, Malek K, Tonelli D, Douillard JY (2006) A phase II study of oral uracil/ftorafur (UFTs) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer. Br J Cancer 94: 69\u201373", "journal-title": "Br J Cancer"}, {"key": "BF6604666_CR8", "doi-asserted-by": "publisher", "first-page": "63", "DOI": "10.1016/j.suronc.2004.09.008", "volume": "13", "author": "GD Beretta", "year": "2004", "unstructured": "Beretta GD, Milesi L, Pessi MA, Mosconi S, Labianca R (2004) Adjuvant treatment of colorectal cancer. Surg Oncol 13: 63\u201373", "journal-title": "Surg Oncol"}, {"key": "BF6604666_CR9", "doi-asserted-by": "publisher", "first-page": "808", "DOI": "10.1016/j.cgh.2006.04.016", "volume": "4", "author": "DM Bernold", "year": "2006", "unstructured": "Bernold DM, Sinicrope FA (2006) Advances in chemotherapy for colorectal cancer. Clin Gastroenterol Hepatol 4: 808\u2013821", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "BF6604666_CR10", "first-page": "15", "volume": "11", "author": "JW Boag", "year": "1949", "unstructured": "Boag JW (1949) Maximum likelihood estimates of the proportion of patients cured by cancer therapy. J Roy Stat Soc B 11: 15\u201353", "journal-title": "J Roy Stat Soc B"}, {"key": "BF6604666_CR11", "doi-asserted-by": "publisher", "first-page": "639", "DOI": "10.2165/00019053-200523070-00001", "volume": "23", "author": "JM Bos", "year": "2005", "unstructured": "Bos JM, Postma MJ, Annemans L (2005) Discounting health effects in pharmacoeconomics evaluations: current Controversies. Pharmacoeconomics 23: 639\u2013649", "journal-title": "Pharmacoeconomics"}, {"key": "BF6604666_CR12", "doi-asserted-by": "publisher", "first-page": "551", "DOI": "10.1097/00042737-200406000-00007", "volume": "16", "author": "AH Briggs", "year": "2004", "unstructured": "Briggs AH (2004) Statistical approaches to handling uncertainty in health economic evaluation. Eur J Gastroenterol Hepatol 16: 551\u2013561", "journal-title": "Eur J Gastroenterol Hepatol"}, {"key": "BF6604666_CR13", "doi-asserted-by": "publisher", "first-page": "446", "DOI": "10.1136/bmj.331.7514.446", "volume": "331", "author": "WB Brouwer", "year": "2005", "unstructured": "Brouwer WB, Niessen LW, Postma MJ, Rutten FF (2005) Need for differential discounting of costs and health effects in cost-effectiveness analyses. BMJ 331: 446\u2013448", "journal-title": "BMJ"}, {"key": "BF6604666_CR14", "doi-asserted-by": "publisher", "first-page": "1008", "DOI": "10.1001/jama.284.8.1008", "volume": "284", "author": "C Camm\u00e0", "year": "2000", "unstructured": "Camm\u00e0 C, Giunta M, Fiorica F, Pagliaro L, Crax\u00ec A, Cottone M (2000) Preoperative radiotherapy for resectable rectal cancer. JAMA 284: 1008\u20131015", "journal-title": "JAMA"}, {"key": "BF6604666_CR15", "doi-asserted-by": "publisher", "first-page": "429", "DOI": "10.1002/hec.853", "volume": "13", "author": "RH Chapman", "year": "2004", "unstructured": "Chapman RH, Berger M, Weinstein MC, Weeks JC, Goldie S, Neumann PJ (2004) When does quality-adjusted life-years matter in cost-effectiveness analysis? Health Econ 13: 429\u2013436", "journal-title": "Health Econ"}, {"key": "BF6604666_CR16", "doi-asserted-by": "publisher", "first-page": "1291", "DOI": "10.1016/S0140-6736(01)06409-1", "volume": "358", "author": "Colorectal Cancer Collaborative Group", "year": "2001", "unstructured": "Colorectal Cancer Collaborative Group (2001) Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomized trials. Lancet 358: 1291\u20131304", "journal-title": "Lancet"}, {"key": "BF6604666_CR17", "unstructured": "Committee of Cancer Statistics (2005) Cancer Statistics 2005. Tokyo (in Japanese): Foundation of Promotion of Cancer Research"}, {"key": "BF6604666_CR18", "author": "MF Drummond", "year": "2005", "unstructured": "Drummond MF, Sculpher MJ, Torrance GW, O\u2019Brien BJ, Stoddart GL (2005) Methods for the Economic Evaluation of Health Care Programmes, 3rd ed Oxford Univ Press: NY", "volume-title": "Methods for the Economic Evaluation of Health Care Programmes"}, {"key": "BF6604666_CR19", "doi-asserted-by": "publisher", "first-page": "3302", "DOI": "10.1200/JCO.2000.18.18.3302", "volume": "18", "author": "CC Earle", "year": "2000", "unstructured": "Earle CC, Chapman RH, Baker CS, Bell CM, Stone PW, Sandberg EA, Neumann PJ (2000) Systematic overview of cost\u2013utility assessments in oncology. J Clin Oncol 18: 3302\u20133317", "journal-title": "J Clin Oncol"}, {"key": "BF6604666_CR20", "doi-asserted-by": "publisher", "first-page": "21", "DOI": "10.1093/jnci/80.1.21", "volume": "80", "author": "B Fisher", "year": "1988", "unstructured": "Fisher B, Wolmark N, Rockette H, Redmond C, Deutsch M, Wickerham DL, Fisher ER, Caplan R, Jones J, Lerner H (1988) Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer. Results from NSABP protocol R-01. J Natl Cancer Inst 80: 21\u201329", "journal-title": "J Natl Cancer Inst"}, {"key": "BF6604666_CR21", "doi-asserted-by": "crossref", "first-page": "89", "DOI": "10.1586/14737167.1.1.25", "volume": "1", "author": "HA Glick", "year": "2001", "unstructured": "Glick HA, Briggs AH, Polsky D (2001) Quantifying stochastic uncertainty and presenting results of cost-effectiveness analyses. Expert Rev Pharmacoeconomics Outcome Res 1: 89\u2013100", "journal-title": "Expert Rev Pharmacoeconomics Outcome Res"}, {"key": "BF6604666_CR22", "author": "MR Gold", "year": "1996", "unstructured": "Gold MR, Siegel JE, Russell LB, Weinstein MC (1996) Cost-Effectiveness in Health and Medicine. Oxford Univ Press: NY", "volume-title": "Cost-Effectiveness in Health and Medicine"}, {"key": "BF6604666_CR23", "author": "AJ Gross", "year": "1975", "unstructured": "Gross AJ, Clark VA (1975) Survival distributions: Reliability Applications in the Biomedical Sciences. John Wiley & Sons: NY", "volume-title": "Survival distributions: Reliability Applications in the Biomedical Sciences"}, {"key": "BF6604666_CR24", "unstructured": "Institute of Social Insurance (2005) Interpretation for Table of Points of Medical Practice. Institute of Social Insurance: Tokyo (in Japanese)"}, {"key": "BF6604666_CR25", "doi-asserted-by": "publisher", "first-page": "537", "DOI": "10.2165/00019053-200725070-00002", "volume": "25", "author": "FGA Jansman", "year": "2007", "unstructured": "Jansman FGA, Postma MJ, Brouwers JRBJ (2007) Cost considerations in the treatment of colorectal cancer. Pharmacoeconomics 25: 537\u2013562", "journal-title": "Pharmacoeconomics"}, {"key": "BF6604666_CR26", "unstructured": "Japanese Society for Cancer of the Colon and Rectum (2005) Treatment Guidelines for Colorectal Cancer, 2005 version, Kanehara: Tokyo (in Japanese)"}, {"key": "BF6604666_CR27", "unstructured": "Jiho (2005) Encyclopedia of Drugs Listed for Insurance. Jiho Inc.: Tokyo (in Japanese)"}, {"issue": "Suppl 4", "key": "BF6604666_CR28", "doi-asserted-by": "publisher", "first-page": "5", "DOI": "10.2165/00019053-200422004-00003", "volume": "22", "author": "B Jonsson", "year": "2004", "unstructured": "Jonsson B (2004) Changing health environment: the challenge to demonstrate cost-effectiveness of new compounds. Pharmacoeconomics 22 (Suppl 4): 5\u201310", "journal-title": "Pharmacoeconomics"}, {"key": "BF6604666_CR29", "doi-asserted-by": "publisher", "first-page": "638", "DOI": "10.1056/NEJMoa010580", "volume": "345", "author": "E Kapiteijn", "year": "2001", "unstructured": "Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, Leer JW, van de Velde CJ, Dutch Colorectal Cancer Group (2001) Preoperative radiotherapy combined with total mesorectal excision for respectable rectal cancer. NEJM 345: 638\u2013646", "journal-title": "NEJM"}, {"key": "BF6604666_CR30", "doi-asserted-by": "publisher", "first-page": "575", "DOI": "10.1007/s00423-002-0278-x", "volume": "386", "author": "T Kato", "year": "2002", "unstructured": "Kato T, Ohashi Y, Nakazato H, Koike A, Saji S, Suzuki H, Takagi H, Nimura Y, Hasumi A, Baba S, Manabe T, Maruta M, Miura K, Yamaguchi A (2002) Efficacy of oral UFT as adjuvant chemotherapy to curative resection of colorectal cancer: multicenter prospective randomized trial. Langenbecks Arch Surg 386: 575\u2013581", "journal-title": "Langenbecks Arch Surg"}, {"key": "BF6604666_CR31", "doi-asserted-by": "publisher", "first-page": "357", "DOI": "10.1007/BF00539213", "volume": "3", "author": "S Kodaira", "year": "1998", "unstructured": "Kodaira S, Kikuchi K, Yasutomi M, Takahashi T, Hojo K, Kato T, Tominaga T, Kunii Y (1998) Postoperative adjuvant chemotherapy with mitomycin C and UFT for curatively resected rectal cancer. Results form the Cooperative Project No.7 Group of the Japanese Foundation for Multidisciplinary Treatment of Cancer. Int J Clin Oncol 3: 357\u2013364", "journal-title": "Int J Clin Oncol"}, {"key": "BF6604666_CR32", "doi-asserted-by": "publisher", "first-page": "105", "DOI": "10.1146/annurev.publhealth.18.1.105", "volume": "18", "author": "ET Lee", "year": "1997", "unstructured": "Lee ET, Go OT (1997) Survival analysis in public health research. Ann Rev Pub Health 18: 105\u2013134", "journal-title": "Ann Rev Pub Health"}, {"key": "BF6604666_CR33", "doi-asserted-by": "publisher", "first-page": "2059", "DOI": "10.1200/JCO.2005.04.7498", "volume": "24", "author": "BC Lembersky", "year": "2006", "unstructured": "Lembersky BC, Wieand HS, Petrelli NJ, O\u2019Connell MJ, Colangelo LH, Smith RE, Seay TE, Giguere JK, Marshall ME, Jacobs AD, Colman LK, Soran A, Yothers G, Wolmark N (2006) Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06. J Clin Oncol 24: 2059\u20132064", "journal-title": "J Clin Oncol"}, {"key": "BF6604666_CR34", "doi-asserted-by": "publisher", "first-page": "419", "DOI": "10.2307/2533947", "volume": "53", "author": "DY Lin", "year": "1997", "unstructured": "Lin DY, Feuer EJ, Etzioni R, Wax Y (1997) Estimating medical costs from incomplete follow-up data. Biometrics 53: 419\u2013434", "journal-title": "Biometrics"}, {"key": "BF6604666_CR35", "doi-asserted-by": "publisher", "first-page": "131", "DOI": "10.1177/0272989X04263253", "volume": "24", "author": "S Maetani", "year": "2004", "unstructured": "Maetani S, Nakajima T, Nishikawa T (2004) Parametric mean survival time analysis in gastric cancer patients. Med Decis Making 24: 131\u2013141", "journal-title": "Med Decis Making"}, {"key": "BF6604666_CR36", "doi-asserted-by": "publisher", "first-page": "484", "DOI": "10.1200/JCO.2004.04.065", "volume": "22", "author": "Meta-Analysis Group of the Japanese Society for Cancer of the Colon and Rectum and the Meta-Analysis Group in Cancer", "year": "2004", "unstructured": "Meta-Analysis Group of the Japanese Society for Cancer of the Colon and Rectum and the Meta-Analysis Group in Cancer (2004) Efficacy of oral adjuvant therapy after resection of colorectal cancer, 5-year results from three randomized trials. J Clin Oncol 22: 484\u2013492", "journal-title": "J Clin Oncol"}, {"key": "BF6604666_CR37", "unstructured": "Ministry of Health, Labor and Welfare (2006) Outline of Vital Statistics. MHLW, (in Japanese)"}, {"key": "BF6604666_CR38", "doi-asserted-by": "publisher", "first-page": "1021", "DOI": "10.1245/ASO.2006.08.015", "volume": "13", "author": "DK Monga", "year": "2006", "unstructured": "Monga DK, O\u2019Connell MJ (2006) Surgical adjuvant therapy for colorectal cancer: current approaches and future directions. Ann Surg Oncol 13: 1021\u20131034", "journal-title": "Ann Surg Oncol"}, {"key": "BF6604666_CR39", "doi-asserted-by": "publisher", "first-page": "409", "DOI": "10.1007/s004230050153", "volume": "383", "author": "T Mori", "year": "1998", "unstructured": "Mori T, Takahashi K, Yasumo M (1998) Radical resection with autonomic nerve preservation and lymph node dissection techniques in lower rectal cancer surgery and its results: the impact of lateral lymph node dissection. Langenbecks Arch Surg 383: 409\u2013415", "journal-title": "Langenbecks Arch Surg"}, {"key": "BF6604666_CR40", "unstructured": "National Institute of Clinical Excellence (2004) Guide to the Methods of Technology Appraisal. NICE: London"}, {"key": "BF6604666_CR41", "doi-asserted-by": "publisher", "first-page": "1650", "DOI": "10.1111/j.1572-0241.1999.01157.x", "volume": "94", "author": "RM Ness", "year": "1999", "unstructured": "Ness RM, Holmes AM, Klein R, Dittus R (1999) Utility valuations for outcome states of colorectal cancer. Am J Gastroenterol 94: 1650\u20131657", "journal-title": "Am J Gastroenterol"}, {"key": "BF6604666_CR42", "doi-asserted-by": "publisher", "first-page": "65", "DOI": "10.1023/A:1008265905933", "volume": "8", "author": "J Norum", "year": "1997", "unstructured": "Norum J, Vonen B, Olsen JA, Revhaug A (1997) Adjuvant chemotherapy (5-fluorouracil and levamisole) in Dukes\u2019 B and C colorectal carcinoma, a cost-effectiveness analysis. Ann Oncol 8: 65\u201370", "journal-title": "Ann Oncol"}, {"key": "BF6604666_CR43", "unstructured": "OECD (2007) GDP PPPs and Delivered Indices for all OECD Countries, OECD Main Economic Indicators. OECD"}, {"key": "BF6604666_CR44", "doi-asserted-by": "publisher", "first-page": "6199", "DOI": "10.1200/JCO.2005.14.779", "volume": "23", "author": "KC Peeters", "year": "2005", "unstructured": "Peeters KC, van de Velde CJ, Leer JW, Martijn H, Junggeburt JM, Kranenbarg EK, Steup WH, Wiggers T, Rutten HJ, Marijnen CA (2005) Late side effect of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients, a Dutch Colorectal Cancer Group Study. J Clin Oncol 23: 6199\u20136206", "journal-title": "J Clin Oncol"}, {"key": "BF6604666_CR45", "doi-asserted-by": "publisher", "first-page": "282", "DOI": "10.1080/02841860151116367", "volume": "40", "author": "P Ragnhammar", "year": "2001", "unstructured": "Ragnhammar P, Hafstr\u00f6m L, Nygren P, Glimelius B, SBU-group. Swedish Council of Technology Assessment in Health Care (2001) A systematic overview of chemotherapy effects in colorectal cancer. Acta Oncologica 40: 282\u2013308", "journal-title": "Acta Oncologica"}, {"key": "BF6604666_CR46", "doi-asserted-by": "publisher", "first-page": "78", "DOI": "10.1093/jjco/29.2.78", "volume": "29", "author": "J Sakamoto", "year": "1999", "unstructured": "Sakamoto J, Hamada C, Kodaira S, Nakazato H, Ohashi Y (1999) Adjuvant therapy with oral fluoropyrimidines as main chemotherapeutic agents after curative resection for colorectal cancer: individual patient data meta-analysis of randomized trials. Jpn J Clin Oncol 29: 78\u201386", "journal-title": "Jpn J Clin Oncol"}, {"key": "BF6604666_CR47", "doi-asserted-by": "publisher", "first-page": "1731", "DOI": "10.1056/NEJMoa040694", "volume": "351", "author": "R Sauer", "year": "2004", "unstructured": "Sauer R, Becker H, Hohenberger W, R\u00f6del C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R, German Rectal Cancer Study Group (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. NEJM 351: 1731\u20131740", "journal-title": "NEJM"}, {"key": "BF6604666_CR48", "doi-asserted-by": "publisher", "first-page": "191", "DOI": "10.1093/jjco/hyl013", "volume": "36", "author": "H Takiuchi", "year": "2006", "unstructured": "Takiuchi H (2006) Adjuvant therapy in rectal cancer: what is the truth? Jpn J Clin Oncol 36: 191\u2013192", "journal-title": "Jpn J Clin Oncol"}, {"key": "BF6604666_CR49", "doi-asserted-by": "publisher", "first-page": "609", "DOI": "10.2165/00019053-200119060-00001", "volume": "19", "author": "P Trueman", "year": "2001", "unstructured": "Trueman P, Drummond M, Hutton J (2001) Developing guidance for budget impact analysis. Pharmacoeconomics 19: 609\u2013621", "journal-title": "Pharmacoeconomics"}, {"key": "BF6604666_CR50", "doi-asserted-by": "publisher", "first-page": "2696", "DOI": "10.1056/NEJMoa043116", "volume": "352", "author": "C Twelves", "year": "2005", "unstructured": "Twelves C, Wong A, Nowacki MP, Abt M, Burris III H, Carrato A, Cassidy J, Cervantes A, Fagerberg J, Georgoulias V, Husseini F, Jodrell D, Koralewski P, Kr\u00f6ning H, Maroun J, Marschner N, McKendrick J, Pawlicki M, Rosso R, Sch\u00fcller J, Seitz JF, Stabuc B, Tujakowski J, Van Hazel G, Zaluski J, Scheithauer W (2005) Capecitabine as adjuvant treatment for stage III colon cancer. NEJM 352: 2696\u20132704", "journal-title": "NEJM"}, {"key": "BF6604666_CR51", "doi-asserted-by": "publisher", "first-page": "953", "DOI": "10.1016/S0959-8049(02)00053-9", "volume": "38", "author": "WB van den Hout", "year": "2002", "unstructured": "van den Hout WB, van den Brink M, Stiggelbout AM, van de Velde CJ, Kievit J (2002) Cost-effectiveness analysis of colorectal cancer treatments. Eur J Cancer 38: 953\u2013963", "journal-title": "Eur J Cancer"}, {"key": "BF6604666_CR52", "author": "AR Willan", "year": "2006", "unstructured": "Willan AR, Briggs AH (2006) Statistical Analysis of Cost-Effectiveness Data. John Wiley & Sons: Chichester", "volume-title": "Statistical Analysis of Cost-Effectiveness Data", "DOI": "10.1002/0470856289", "doi-asserted-by": "publisher"}], "container-title": ["British Journal of Cancer"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/6604666.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/6604666", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/6604666.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 14]], "date-time": "2019-04-14T04:41:30Z", "timestamp": 1555216890000}, "score": 37.365826, "issued": {"date-parts": [[2008, 9, 16]]}, "references-count": 52, "journal-issue": {"published-print": {"date-parts": [[2008, 10]]}, "issue": "8"}, "alternative-id": ["BF6604666"], "URL": "http://dx.doi.org/10.1038/sj.bjc.6604666", "relation": {"cites": []}, "ISSN": ["0007-0920", "1532-1827"], "issn-type": [{"value": "0007-0920", "type": "print"}, {"value": "1532-1827", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T06:02:05Z", "timestamp": 1574402525420}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2011, 9, 1]], "date-time": "2011-09-01T00:00:00Z", "timestamp": 1314835200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Journal of Cancer"], "published-print": {"date-parts": [[2011, 9]]}, "DOI": "10.1016/s0959-8049(11)72320-6", "type": "journal-article", "created": {"date-parts": [[2011, 9, 24]], "date-time": "2011-09-24T18:43:33Z", "timestamp": 1316889813000}, "page": "S594", "source": "Crossref", "is-referenced-by-count": 1, "title": ["9008 ORAL Randomized Phase III Trial of Adjuvant Chemotherapy With Gemcitabine Compared With Oral Tegafur-uracil (UFT) in Resected, Stage IB-llla Non-small Cell Lung Cancer (WJTOG 0101)"], "prefix": "10.1016", "volume": "47", "author": [{"given": "T.", "family": "Mitsudomi", "sequence": "first", "affiliation": []}, {"given": "H.", "family": "Tada", "sequence": "additional", "affiliation": []}, {"given": "Y.", "family": "Ichinose", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Yokoi", "sequence": "additional", "affiliation": []}, {"given": "N.", "family": "Katakami", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Oda", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Negoro", "sequence": "additional", "affiliation": []}, {"given": "Y.", "family": "Chiba", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Nakagawa", "sequence": "additional", "affiliation": []}, {"given": "Y.", "family": "Nakanishi", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Journal of Cancer"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0959804911723206?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0959804911723206?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 11, 29]], "date-time": "2018-11-29T22:21:11Z", "timestamp": 1543530071000}, "score": 37.17113, "issued": {"date-parts": [[2011, 9]]}, "references-count": 0, "alternative-id": ["S0959804911723206"], "URL": "http://dx.doi.org/10.1016/s0959-8049(11)72320-6", "ISSN": ["0959-8049"], "issn-type": [{"value": "0959-8049", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T23:54:51Z", "timestamp": 1576799691407}, "reference-count": 0, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "14_suppl", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2004, 7, 15]]}, "DOI": "10.1200/jco.2004.22.14_suppl.3524", "type": "journal-article", "created": {"date-parts": [[2017, 4, 5]], "date-time": "2017-04-05T08:02:15Z", "timestamp": 1491379335000}, "page": "3524-3524", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Adjuvant oral uracil and tegafur (UFT) improves survival after complete mesorectal excision (ME) for pathologic TNM stage III rectal cancer (RC): Results of the National Surgical Adjuvant Study (NSAS)-Colorectal Cancer (CC) 01 randomized trial"], "prefix": "10.1200", "volume": "22", "author": [{"given": "T.", "family": "Akasu", "sequence": "first", "affiliation": [{"name": "National Cancer Center Hospital, Tokyo, Japan; National Cancer Center Hospital East, Kashiwa, Japan; University of Tokyo, Tokyo, Japan; Teikyo University, Tokyo, Japan"}]}, {"given": "Y.", "family": "Moriya", "sequence": "additional", "affiliation": [{"name": "National Cancer Center Hospital, Tokyo, Japan; National Cancer Center Hospital East, Kashiwa, Japan; University of Tokyo, Tokyo, Japan; Teikyo University, Tokyo, Japan"}]}, {"given": "S.", "family": "Yoshida", "sequence": "additional", "affiliation": [{"name": "National Cancer Center Hospital, Tokyo, Japan; National Cancer Center Hospital East, Kashiwa, Japan; University of Tokyo, Tokyo, Japan; Teikyo University, Tokyo, Japan"}]}, {"given": "K.", "family": "Shirao", "sequence": "additional", "affiliation": [{"name": "National Cancer Center Hospital, Tokyo, Japan; National Cancer Center Hospital East, Kashiwa, Japan; University of Tokyo, Tokyo, Japan; Teikyo University, Tokyo, Japan"}]}, {"given": "Y.", "family": "Ohashi", "sequence": "additional", "affiliation": [{"name": "National Cancer Center Hospital, Tokyo, Japan; National Cancer Center Hospital East, Kashiwa, Japan; University of Tokyo, Tokyo, Japan; Teikyo University, Tokyo, Japan"}]}, {"given": "S.", "family": "Kodaira", "sequence": "additional", "affiliation": [{"name": "National Cancer Center Hospital, Tokyo, Japan; National Cancer Center Hospital East, Kashiwa, Japan; University of Tokyo, Tokyo, Japan; Teikyo University, Tokyo, Japan"}]}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/jco.2004.22.14_suppl.3524", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T22:04:06Z", "timestamp": 1574892246000}, "score": 35.59929, "issued": {"date-parts": [[2004, 7, 15]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2004, 7, 15]]}, "issue": "14_suppl"}, "alternative-id": ["10.1200/jco.2004.22.14_suppl.3524"], "URL": "http://dx.doi.org/10.1200/jco.2004.22.14_suppl.3524", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T23:55:56Z", "timestamp": 1576799756647}, "reference-count": 0, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "14_suppl", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2004, 7, 15]]}, "DOI": "10.1200/jco.2004.22.90140.3524", "type": "journal-article", "created": {"date-parts": [[2017, 4, 5]], "date-time": "2017-04-05T07:17:42Z", "timestamp": 1491376662000}, "page": "3524-3524", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Adjuvant oral uracil and tegafur (UFT) improves survival after complete mesorectal excision (ME) for pathologic TNM stage III rectal cancer (RC): Results of the National Surgical Adjuvant Study (NSAS)-Colorectal Cancer (CC) 01 randomized trial"], "prefix": "10.1200", "volume": "22", "author": [{"given": "T.", "family": "Akasu", "sequence": "first", "affiliation": [{"name": "National Cancer Center Hospital, Tokyo, Japan; National Cancer Center Hospital East, Kashiwa, Japan; University of Tokyo, Tokyo, Japan; Teikyo University, Tokyo, Japan"}]}, {"given": "Y.", "family": "Moriya", "sequence": "additional", "affiliation": [{"name": "National Cancer Center Hospital, Tokyo, Japan; National Cancer Center Hospital East, Kashiwa, Japan; University of Tokyo, Tokyo, Japan; Teikyo University, Tokyo, Japan"}]}, {"given": "S.", "family": "Yoshida", "sequence": "additional", "affiliation": [{"name": "National Cancer Center Hospital, Tokyo, Japan; National Cancer Center Hospital East, Kashiwa, Japan; University of Tokyo, Tokyo, Japan; Teikyo University, Tokyo, Japan"}]}, {"given": "K.", "family": "Shirao", "sequence": "additional", "affiliation": [{"name": "National Cancer Center Hospital, Tokyo, Japan; National Cancer Center Hospital East, Kashiwa, Japan; University of Tokyo, Tokyo, Japan; Teikyo University, Tokyo, Japan"}]}, {"given": "Y.", "family": "Ohashi", "sequence": "additional", "affiliation": [{"name": "National Cancer Center Hospital, Tokyo, Japan; National Cancer Center Hospital East, Kashiwa, Japan; University of Tokyo, Tokyo, Japan; Teikyo University, Tokyo, Japan"}]}, {"given": "S.", "family": "Kodaira", "sequence": "additional", "affiliation": [{"name": "National Cancer Center Hospital, Tokyo, Japan; National Cancer Center Hospital East, Kashiwa, Japan; University of Tokyo, Tokyo, Japan; Teikyo University, Tokyo, Japan"}]}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/jco.2004.22.90140.3524", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T21:48:23Z", "timestamp": 1574891303000}, "score": 35.59929, "issued": {"date-parts": [[2004, 7, 15]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2004, 7, 15]]}, "issue": "14_suppl"}, "alternative-id": ["10.1200/jco.2004.22.90140.3524"], "URL": "http://dx.doi.org/10.1200/jco.2004.22.90140.3524", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T22:17:56Z", "timestamp": 1574288276141}, "reference-count": 2, "publisher": "Springer Science and Business Media LLC", "issue": "9", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2007, 4, 17]], "date-time": "2007-04-17T00:00:00Z", "timestamp": 1176768000000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Br J Cancer"], "published-print": {"date-parts": [[2007, 5]]}, "DOI": "10.1038/sj.bjc.6603739", "type": "journal-article", "created": {"date-parts": [[2007, 4, 17]], "date-time": "2007-04-17T10:43:01Z", "timestamp": 1176806581000}, "page": "1490-1490", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Reply: The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer"], "prefix": "10.1038", "volume": "96", "author": [{"given": "S E", "family": "Ward", "sequence": "first", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2007, 4, 17]]}, "reference": [{"key": "BF6603739_CR1", "first-page": "42", "volume": "13", "author": "D Ollendorf", "year": "1999", "unstructured": "Ollendorf D (1999) Impact of uracil/tegafur plus oral calcium folinate on resource utilization. Oncology 13(7 Suppl 3): 42\u201343", "journal-title": "Oncology"}, {"key": "BF6603739_CR2", "unstructured": "Ward SE, Kaltenthaler E, Cowan J, Brewer N (2003) Clinical and cost effectiveness of capecitabine and tegafur with uracil for the treatment of metastatic colorectal cancer: systematic review and economic evaluation. Health Tech Assess 7(32)", "DOI": "10.3310/hta7320", "doi-asserted-by": "crossref"}], "container-title": ["British Journal of Cancer"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/6603739.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/6603739", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/6603739.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 27]], "date-time": "2019-04-27T10:18:26Z", "timestamp": 1556360306000}, "score": 34.62564, "issued": {"date-parts": [[2007, 4, 17]]}, "references-count": 2, "journal-issue": {"published-print": {"date-parts": [[2007, 5]]}, "issue": "9"}, "alternative-id": ["BF6603739"], "URL": "http://dx.doi.org/10.1038/sj.bjc.6603739", "relation": {"cites": []}, "ISSN": ["0007-0920", "1532-1827"], "issn-type": [{"value": "0007-0920", "type": "print"}, {"value": "1532-1827", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T22:17:56Z", "timestamp": 1574288276143}, "reference-count": 4, "publisher": "Springer Science and Business Media LLC", "issue": "9", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2007, 4, 17]], "date-time": "2007-04-17T00:00:00Z", "timestamp": 1176768000000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Br J Cancer"], "published-print": {"date-parts": [[2007, 5]]}, "DOI": "10.1038/sj.bjc.6603738", "type": "journal-article", "created": {"date-parts": [[2007, 4, 17]], "date-time": "2007-04-17T10:43:01Z", "timestamp": 1176806581000}, "page": "1489-1489", "source": "Crossref", "is-referenced-by-count": 2, "title": ["The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer"], "prefix": "10.1038", "volume": "96", "author": [{"given": "J", "family": "Almond", "sequence": "first", "affiliation": []}, {"given": "S", "family": "Ralston", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2007, 4, 17]]}, "reference": [{"key": "BF6603738_CR1", "unstructured": "Monthly Index of Medical Specialities April 2006"}, {"key": "BF6603738_CR2", "first-page": "263a", "volume": "18", "author": "R Pazdur", "year": "1999", "unstructured": "Pazdur R, Douillard JY, Skillings JR, Eisenberg PD, Davidson N, Harper P, Vincent MD, Lembersky BC (1999) Multicenter phase III study of 5-fluorouracil (5-FU) or UFT in combination with leucovorin (LV) in patients with metastatic colorectal cancer. Proc Am Soc Clin Oncol 18: 263a abstract 1009", "journal-title": "Proc Am Soc Clin Oncol"}, {"key": "BF6603738_CR3", "unstructured": "Roche (2002) Xeloda (capecitabine): achieving clinical excellence in the treatment of metastatic colorectal cancer. Roche submission to the National Institute for Clinical Excellence"}, {"key": "BF6603738_CR4", "doi-asserted-by": "publisher", "first-page": "27", "DOI": "10.1038/sj.bjc.6603215", "volume": "95", "author": "SE Ward", "year": "2006", "unstructured": "Ward SE, Kaltenthaler E, Cowan J, Marples M, Orr B, Seymour MT (2006) The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer. Br J Cancer 95: 27\u201334 doi:10.1038/sj.bjc.6603215", "journal-title": "Br J Cancer"}], "container-title": ["British Journal of Cancer"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/6603738.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/6603738", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/6603738.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 14]], "date-time": "2019-04-14T04:07:32Z", "timestamp": 1555214852000}, "score": 34.62564, "issued": {"date-parts": [[2007, 4, 17]]}, "references-count": 4, "journal-issue": {"published-print": {"date-parts": [[2007, 5]]}, "issue": "9"}, "alternative-id": ["BF6603738"], "URL": "http://dx.doi.org/10.1038/sj.bjc.6603738", "relation": {"cites": []}, "ISSN": ["0007-0920", "1532-1827"], "issn-type": [{"value": "0007-0920", "type": "print"}, {"value": "1532-1827", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 29]], "date-time": "2019-11-29T18:36:35Z", "timestamp": 1575052595025}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "5", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1996, 8, 5]], "date-time": "1996-08-05T00:00:00Z", "timestamp": 839203200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Chemotherapy and Pharmacology"], "published-print": {"date-parts": [[1996, 8, 5]]}, "DOI": "10.1007/s002800050503", "type": "journal-article", "created": {"date-parts": [[2002, 8, 25]], "date-time": "2002-08-25T08:03:26Z", "timestamp": 1030262606000}, "page": "401-405", "source": "Crossref", "is-referenced-by-count": 9, "title": ["Thymidylate synthase inhibition by an oral regimen consisting of tegafur-uracil (UFT) and low-dose leucovorin for patients with gastric cancer"], "prefix": "10.1007", "volume": "38", "author": [{"given": "T.", "family": "Ichikura", "sequence": "first", "affiliation": []}, {"given": "S.", "family": "Tomimatsu", "sequence": "additional", "affiliation": []}, {"given": "Y.", "family": "Okusa", "sequence": "additional", "affiliation": []}, {"given": "T.", "family": "Yahara", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Uefuji", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Tamakuma", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["Cancer Chemotherapy and Pharmacology"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s002800050503.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s002800050503/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s002800050503", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 28]], "date-time": "2019-05-28T10:07:47Z", "timestamp": 1559038067000}, "score": 34.613087, "issued": {"date-parts": [[1996, 8, 5]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1996, 8, 5]]}, "issue": "5"}, "alternative-id": ["3ATXECJYG1L5XWN7"], "URL": "http://dx.doi.org/10.1007/s002800050503", "ISSN": ["0344-5704", "1432-0843"], "issn-type": [{"value": "0344-5704", "type": "print"}, {"value": "1432-0843", "type": "electronic"}], "subject": ["Toxicology", "Pharmacology (medical)", "Cancer Research", "Oncology", "Pharmacology"]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T20:42:37Z", "timestamp": 1574368957825}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "7", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2008, 4, 1]], "date-time": "2008-04-01T00:00:00Z", "timestamp": 1207008000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Journal of Cancer Supplements"], "published-print": {"date-parts": [[2008, 4]]}, "DOI": "10.1016/s1359-6349(08)70551-2", "type": "journal-article", "created": {"date-parts": [[2008, 5, 10]], "date-time": "2008-05-10T09:40:48Z", "timestamp": 1210412448000}, "page": "117-118", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Relationship between estrogen receptor (ER) status and efficacy of postoperative adjuvant chemotherapy with oral tegafur-uracil (UFT) or CMF: subset analysis from a randomized controlled trial (CUBC trial in Japan)"], "prefix": "10.1016", "volume": "6", "author": [{"given": "Y.", "family": "Takatsuka", "sequence": "first", "affiliation": []}, {"given": "Y.", "family": "Park", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Okamura", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Mitsuyama", "sequence": "additional", "affiliation": []}, {"given": "T.", "family": "Saito", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Koh", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Kyono", "sequence": "additional", "affiliation": []}, {"given": "H.", "family": "Inaji", "sequence": "additional", "affiliation": []}, {"given": "H.", "family": "Koyama", "sequence": "additional", "affiliation": []}, {"given": "T.", "family": "Suzuki", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Journal of Cancer Supplements"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1359634908705512?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1359634908705512?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 28]], "date-time": "2018-12-28T22:21:20Z", "timestamp": 1546035680000}, "score": 34.381, "issued": {"date-parts": [[2008, 4]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2008, 4]]}, "issue": "7"}, "alternative-id": ["S1359634908705512"], "URL": "http://dx.doi.org/10.1016/s1359-6349(08)70551-2", "ISSN": ["1359-6349"], "issn-type": [{"value": "1359-6349", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T23:16:55Z", "timestamp": 1574119015472}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "5", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2003, 9, 1]], "date-time": "2003-09-01T00:00:00Z", "timestamp": 1062374400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Journal of Cancer Supplements"], "published-print": {"date-parts": [[2003, 9]]}, "DOI": "10.1016/s1359-6349(03)90594-5", "type": "journal-article", "created": {"date-parts": [[2004, 4, 18]], "date-time": "2004-04-18T02:00:02Z", "timestamp": 1082253602000}, "page": "S170", "source": "Crossref", "is-referenced-by-count": 0, "title": ["562 Dihydropyrimidine dehydrogenase (DPD) activity in peripheral mononuclear cells (PMNC-DPD) during long-term treatment with oral uracll/tegafur (UFT) as postoperative adjuvant chemotherapy for colorectal cancer (CRC)"], "prefix": "10.1016", "volume": "1", "author": [{"given": "K.", "family": "Ishikawa", "sequence": "first", "affiliation": []}, {"given": "S.", "family": "Sadahiro", "sequence": "additional", "affiliation": []}, {"given": "T.", "family": "Suzuki", "sequence": "additional", "affiliation": []}, {"given": "H.", "family": "Makuuchi", "sequence": "additional", "affiliation": []}, {"given": "C.", "family": "Murayama", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Journal of Cancer Supplements"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1359634903905945?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1359634903905945?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 13]], "date-time": "2019-02-13T04:21:35Z", "timestamp": 1550031695000}, "score": 34.18064, "issued": {"date-parts": [[2003, 9]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2003, 9]]}, "issue": "5"}, "alternative-id": ["S1359634903905945"], "URL": "http://dx.doi.org/10.1016/s1359-6349(03)90594-5", "ISSN": ["1359-6349"], "issn-type": [{"value": "1359-6349", "type": "print"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}